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Abstract 
 
Accurate cell division is a strictly ordered, highly regulated event. In mitosis, a robust 
spindle checkpoint ensures that chromosome division errors occur at a relatively low 
frequency, maintaining high levels of cyclin B1 and securin until chromosomes are 
accurately aligned. In contrast, in mouse oocytes, cyclin B1 and securin are targeted for 
destruction in late prometaphase I, at a time when the spindle is yet to fully migrate to the 
cortex and checkpoint proteins are still at kinetochores. This has been suggested to be 
symptomatic of an inefficient spindle checkpoint in meiosis I oocytes and a potential 
contributor to the high rates of aneuploidy observed in human oocytes. Curiously however, 
these observations have been made in mouse oocytes which ordinarily experience much 
lower rates of error. The seemingly early loss of cyclin B1 and securin rarely has a 
negative impact. This study demonstrates that cyclin B1 and securin destruction in late 
prometaphase I is not simply due to an inefficient spindle checkpoint, but instead due to 
controlled novel mechanisms of destruction within the oocyte. Meiotic cyclin B1 and 
securin destruction can in fact be split into two distinct periods; a later period that 
resembles mitotic destruction where the D-box is sufficient for APC/C targeting, and a 
much earlier period of destruction requiring previously unidentified motifs able to bypass 
the spindle checkpoint. Due to the location of these motifs, it is likely that they are hidden 
when in complex; cyclin B1 with Cdk1 and securin with separase. A model is proposed by 
which free pools of cyclin B1 and securin act as buffer zones, protecting Cdk1 activity and 
separase inhibition when the spindle checkpoint may become insufficient over the 
extended prometaphase period in the huge cell volume of an oocyte. Furthermore, meiotic 
cyclin A2 regulation is investigated. When put alongside cyclin B1 and securin data this 
begins to shed light on overall APC/C processivity in meiosis I. 
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Chapter 1: General introduction. 
In this chapter, I will introduce general themes underlying the study. These include 
progression through the female meiotic cell cycle, oogenesis and aneuploidy. I will also 
discuss how the method of spindle assembly and the checkpoint which protects this assembly 
vary between mitosis and meiosis. Each results chapter will include a separate, in-depth 
introduction focusing on the literature relevant to the data presented in that chapter. 
1.1 Meiosis, oogenesis and aneuploidy 
Meiosis is the specialised cell division in which a diploid progenitor cell undergoes two 
sequential rounds of division without an intermediate DNA synthesis phase, to produce a 
haploid gamete. The first meiotic division (MI) involves the division of the homologous pairs 
of chromosomes, in the case of humans from 46 to 23 pairs and in mice from 40 to 20 pairs. 
MI is therefore described as a reductional division. The second meiotic division (MII) is more 
like mitosis, in that sister chromatids are segregated in a division described as equational.  
Following MI and MII, the subsequent fusion of two haploid gametes, the egg from the 
maternal side and the spermatozoa from the paternal side, takes place during fertilisation to 
re-establish a diploid zygote with half the genetic material from each parent. A schematic 
diagram highlighting the important features of female meiosis I and II is shown in fig. 1.1. 
Anomalies are extremely common in human gametes with ~9% of spermatozoa and ~21% of 
oocytes being abnormal. The types of abnormalities are very different and have a different 
impact on human wellbeing. Spermatozoa are produced in their millions and the majority of 
abnormalities are structural. On the other hand, most ovulatory cycles involve the release of a 
single oocyte and most abnormal oocytes are aneuploid (Martin 2008). This study was 
conducted in MI mouse oocytes and therefore the focus hereafter will be female rather than 
male meiosis.  
Prior to meiosis I, connections or crossovers between homologous chromosomes are 
established during a process known as homologous recombination. This takes place during 
early oocyte development within the foetus and functions to allow exchange of genetic 
material between maternal and paternal chromosomes. Homologous pairs of maternal and 
paternal chromosomes are first paired together by the synaptonemal complex, a molecular 
‘zipper’ that provides the scaffolding for crossover to take place (see Hunter 2015 for review). 
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Figure 1.1. An overview of mammalian female meiosis. (A) Crossovers are established during 
early oocyte development in the foetus, allowing exchange of genetic material between maternal 
and paternal chromosomes. Any future offspring will therefore be genetically diverse from either 
parent cell. Following crossover, oocytes arrest in the germinal vesicle (GV) stage and are stored 
in the ovary. The oocyte remains in this prolonged growth phase until it is released from the ovary, 
following puberty. (B) When the egg is released from the ovary, during the monthly menstrual 
cycle, the GV breaks down (GVBD) and MI resumes. Bivalent pairs of chromosomes are aligned 
on the spindle over many hours, requiring multiple rounds of error correction to reposition homol-
ogous pairs. (C) Following alignment, there is an asymmetric division in which one half of 
homologous chromosomes remain within the large oocyte while the other half is lost in the extru-
sion of the first polar body (PB1) which eventually degenerates. (D) As the oocyte progresses into 
MII it is arrested in metaphase II and relocates to the oviduct. (E) If fertilised, the now mature egg 
progresses into anaphase II, in which sister chromatids are segregated. This is followed by extru-
sion of the second polar body, leaving a human egg with 23 maternal sister chromatids and the 23 
paternal sister chromatids from the male nuclei. The membranes of these 2 pro nuclei dissolve to 
allow fusion of the genetic material and entry into the first mitosis and embryonic cell divisions. 
A. B. C. D. E.
2
Crossover between the sister chromatids of homologous pairs results in chromatids with a 
combination of maternal and paternal DNA. Any future offspring will therefore be genetically 
diverse from either parent cell. 
Following crossover, there is a switch in the function of the cohesin ring structures that 
previously held sister chromatids together. While cohesin complexes located closer the 
centromere remain holding sisters together, those located distally to crossover sites switch 
towards holding homologous chromosomes together as crossover sites are resolved. This 
newly formed pair of chromosomes is termed a bivalent (Watanabe & Nurse 1999; Webster & 
Schuh 2017).  
After formation of bivalents, oocytes arrest in the germinal vesicle (GV) or dictyate stage and 
are stored in the ovary, surrounded by a thin layer of follicular cells in a state known as the 
primordial follicle (Webster & Schuh 2017). Over multiple decades in humans, or many 
weeks in mice, the primordial follicle undergoes an extended growth phase, nursed by 
follicular cells (Herlands & Schultz 1984). The oocyte remains in this prolonged growth 
phase until a time when, following puberty, a cyclical increase in luteinising hormone (LH) 
released by the pituitary gland results in its release from the ovary (ovulation). The germinal 
vesicle of this prophase-arrested oocyte breaks down (GVBD) and MI resumes (Webster & 
Schuh 2017).  
Bivalent pairs of chromosomes are then arranged and aligned on the meiotic spindle apparatus 
over many hours, requiring multiple rounds of error correction to reposition homologous pairs 
(Kitajima et al. 2011). The mechanisms of spindle assembly in human and mouse oocytes are 
not only vastly different from that in mitotic cells, but also distinct from each other. 
Mechanisms of meiotic spindle assembly will be discussed in more detail in section 1.3.   
While chromosomes are aligning on the spindle, levels of cyclin B1-Cdk1 activity must be 
kept high to drive the progression of both mitotic and meiotic cell division (Ledan et al. 2001; 
Gavet & Pines 2010).  At the same time, inhibition of separase by securin must be maintained 
to prevent premature cleavage of cohesin before chromosomes are bi-oriented and under 
tension (Ciosk et al. 1998). In mitosis, destruction of cyclin B1 and securin is restrained by 
the spindle checkpoint (discussed further in section 1.4) until all chromosomes become 
correctly aligned (Lara-Gonzalez et al. 2012). In brief, spindle checkpoint proteins serve to 
sequester Cdc20, a co-activator of the giant E3 ubiquitin ligase, the Anaphase Promoting 
Complex or Cyclosome (APC/C; Di Fiore et al. 2016). On correct alignment, the spindle 
checkpoint ceases and Cdc20 becomes free to bind to the APC/C and form a bipartite receptor 
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with the APC10 subunit that recognises short D-box degrons within APC/C substrates (Chao 
et al. 2012; He et al. 2013). Cyclin B1 and securin are then targeted for degradation via their 
D-box motifs driving mitotic exit and sister chromatid segregation. See Figure 1.2 for a 
schematic diagram showing regulation of mitotic progression. 
In contrast to mitosis in which a single unattached kinetochore is sufficient to generate 
enough of a checkpoint signal to prevent degradation of metaphase APC/C substrates (Lara-
Gonzalez et al. 2012), in meiosis I mouse oocytes cyclin B1 and securin degradation is 
initiated in late prometaphase (Homer et al. 2005). This takes place before all chromosomes 
are congressed and kinetochore attachments are stabilised (Kitajima et al. 2011) and is 
perhaps suggestive of a spindle checkpoint that is inefficient over the large volume of an 
oocyte. However this seems contradictory as mouse oocytes are rarely aneuploid, with errors 
present in only 1-2% of fertilised mouse eggs (Bond & Chandley 1983). In contrast, 
aneuploidy rates in human female oocytes are much higher and will be discussed in section 
1.2. 
In oocytes, prior to anaphase I, separase activation allows for cleavage of the Rec8 kleisin 
subunit, specific to meiotic cohesin (Buonomo et al. 2000). In MI this only occurs on 
chromosomes arms since while distal cohesin is readily targeted, proximal cohesin is 
protected from cleavage by Shugoshin-2 (Sgol2) which recruits PP2A, removing the 
phosphorylations essential for cohesin cleavage (Lee et al. 2008). This allows for segregation 
of homologous chromosomes while sister chromatids remain strongly attached over their 
centromeric regions. Following anaphase I, there is an asymmetric division in which one half 
of homologous chromosomes remain within the large oocyte while the other half is lost in the 
extrusion of the first polar body (PB1) which eventually degenerates. Important to note is the 
extended time over which MI is executed in mammalian oocytes, lasting 7-11 hours in mice 
and 24-36 hours in humans, this is in stark contrast to mitosis which often lasts less than an 
hour (Homer 2013). 
As the oocyte progresses to MII it is arrested in metaphase II and relocates to the oviduct 
(Webster & Schuh 2017). If fertilised, the now mature egg completes MII (Clift & Schuh 
2013). Shugoshin proteins that previously protected centromeric cohesin during the first 
meiotic division have been reported to dissociate away from the centromere in MII in a 
tension-dependent manner (Gómez et al. 2007; Nerusheva et al. 2014). However, a more 
recent study questions whether or not the tension model is the full story since in yeast, sister 
chromatid biorientation is not sufficient to permit Rec8 de-protection during meiosis II (Jonak 
et al. 2017). Instead they suggest that APC/C-Cdc20 targeting of Sgo1 and Mps1, and  
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Figure 1.2. General model for the regulation of mitotic progression through APC/C-medi-
ated cyclin B1 and securin destruction. (A) While chromosomes are aligning on the spindle, 
a robust spindle assembly checkpoint (SAC) inhibits APC/C activity through sequestration of 
APC/C co-activator Cdc20. This maintains high levels of cyclin B1-Cdk1 activity to drive the 
early stages of mitosis and high levels of securin which acts to inhibit separase, preventing 
premature cleavage of cohesin.(B) Once chromosomes are correctly aligned, the SAC ceases 
and APC/C-Cdc20 targets cyclin B1 and securin for proteasomal degradation via their D-box 
motifs.Cyclin B1 degradation inactivates Cdk1 which drives anaphase onset, while securin 
degradation activates separase allowing for cleavage of cohesin and segregation of sister 
chromatids. 
A. B.
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subsequent removal of PP2A from centromeres is necessary. They propose that in yeast, Rec8 
is protected until anaphase II onset, at which point it is phosphorylated in time with separase 
activation (Jonak et al. 2017). Co-localisation of I2PP2A with PP2A at the centromeres in 
metaphase II has also been shown to play a role in centromeric Rec8 de-protection through 
direct inhibition PP2A function (Chambon et al. 2013). 
Together these mechanisms allow for segregation of sister chromatids in anaphase II. This is 
followed by extrusion of the second polar body, leaving a human zygote with 23 maternal 
sister chromatids and the 23 paternal sister chromatids from the male nuclei. The membranes 
of these 2 pro nuclei dissolve to allow fusion of the genetic material (syngamy) and entry into 
the first mitosis and subsequent embryonic cell divisions (Webster & Schuh 2017). 
In oocytes, sister chromatid cohesion is lost in an age-dependent manner, partially mediated 
by down regulation of Sgo2 and cohesin (Lister et al. 2010; Wassmann 2013). This is thought 
to be a major contributor to the ageing effect. While this clearly has a great effect on 
segregation errors, instead this study focuses on understanding the roles of fundamental cell 
cycle proteins in younger, healthy oocytes. 
In contrast to meiosis in mouse oocytes, human female meiosis is extremely error prone, with 
an estimated 10-30% of fertilised eggs carrying an incorrect number of chromosomes 
(Hassold & Hunt 2001). 80-90% of these errors are thought to originate in meiosis I (Homer 
2011). This loss or gain of chromosomes is known as aneuploidy and is the leading genetic 
cause of miscarriage and developmental defects in babies that survive to term (Hassold & 
Hunt 2001). On top of this, there is an exponential increase in the frequency of meiotic 
missegregation observed in women over the age of 35 (Hassold & Hunt 2001). Indeed woman 
who conceive over the age of 40 are 30% more likely to become pregnant with a trisomic 
child (Nagaoka et al. 2012). A problem confounded by the growing trend in the western world 
towards having children later in life, a societal shift that has led to a 70% increase in trisomic 
pregnancies over a 30 year period (Touati & Wassmann 2016). While the reasons why human 
oocytes have such a high frequency of segregation errors when compared to mouse oocytes 
remains largely elusive, the question can at least begin to be answered by looking at the 
different mechanisms they employ to assemble their MI spindle. However to begin with, I 
will introduce the mechanisms of mitotic spindle assembly. 
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1.2 Mechanisms of spindle assembly 
In mitotic cells, two centrosomes positioned at opposite spindle poles form the basis for 
bipolar spindle establishment. Initially positioned together at the start of mitosis, having 
duplicated in G1/S phase, the centrosomes must separate and position themselves at opposite 
poles across the nucleus prior to nuclear envelope breakdown (NEBD) (Tanenbaum & 
Medema 2010). Following NEBD, microtubules emanating from each of these poles firstly 
capture and then accurately align chromosomes on the spindle. Microtubules then retract, 
mediating chromosome segregation in anaphase. The presence of more than two centrosomes 
within a cell, a situation often observed in cancer, is associated with multipolar spindle 
formation and an increase in segregation defects (Silkworth et al. 2009; Webster & Schuh 
2017). 
In contrast, spindle assembly in mouse oocytes is mediated by self-arranging microtubule 
organising centres (MTOCs) lacking any canonical centrosomes (Schuh & Ellenberg 2007). 
Early spindle assembly in mouse meiosis involves microtubule nucleation from around 80 
newly-fragmented MTOCs, which form a large sphere throughout the ooplasm (Schuh & 
Ellenberg 2007; Clift et al. 2009). MTOCs then merge over time and the oocyte goes through 
multiple rounds of error correction, eventually forming the characteristic barrel-shaped 
bipolar spindle in the center of the oocyte (Schuh & Ellenberg 2007; Kitajima et al. 2011).  
Even between closely related mammalian species, the mechanism of meiotic spindle assembly 
seems to be divergent. In human female meiosis, the mechanism of spindle assembly is 
different once again, taking place independently of both centrosomes and MTOCs 
(Holubcova et al. 2015). Instead, microtubule nucleation is mediated directly by the 
chromosomes themselves and the small GTPase, Ran (Holubcova et al. 2015). A T24N 
mutation that blocks the GTPase function on Ran causes a delayed and disorganised spindle 
assembly, yet does not prevent assembly altogether (Holubcova et al. 2015). Microtubules 
nucleating directly from chromosomes form an aster, which over a prolonged period of 
around 16 hours eventually develops into a stable bipolar spindle (Holubcova et al. 2015). 
This method of chromosome-mediated spindle assembly is intrinsically error-prone and may 
begin to explain why human oocytes have such a higher frequency of segregation defects 
when compared to mice.  
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1.3 The Spindle Checkpoint in mitosis and meiosis 
1.3.1 The spindle checkpoint in mitosis 
The spindle checkpoint detects microtubule occupancy of kinetochores; the multi-protein 
microtubule attachment site located near the centromere of each chromosome. A graded 
checkpoint response is stimulated at these sites of attachment, the strength of which is directly 
related to kinetochore occupancy by microtubules (Collin et al. 2013; Touati & Wassmann 
2016). While chromosomes are aligning on the spindle, there are often errors made in 
attachments as the cell attempts to perfect bi-orientation. The response at sites of erroneous 
attachment is to stimulate the assembly of the mitotic checkpoint complex (MCC), a multi-
protein complex that directly sequesters the APC/C co-activator, Cdc20 (Chao et al. 2012).  
Central to MCC assembly is Aurora B, a key component of the Chromosomal Passenger 
Complex (CPC), enriched at incorrectly attached kinetochores (Musacchio 2015) and 
involved in a positive feedback loop with Mps1 where both proteins are recruited to 
unattached kinetochores (Santaguida et al. 2010). The process of MCC assembly begins when 
Mps1 phosphorylates MELT motifs within the kinetochore scaffold protein Knl1, allowing 
for recruitment of spindle checkpoint proteins Bub1, Bub3, BubR1, Mad1, Mad2 and Cdc20 
(Musacchio 2015). The MCC, which comprises Bub3, BubR1, Mad2 and Cdc20 is then 
subsequently enriched in the cytoplasm and functions to inhibit APC/C through direct 
sequestration of both APC/C-bound and free Cdc20 (Di Fiore et al. 2016). Mechanisms of 
Cdc20 sequestration by the MCC are discussed in more detail in chapter 5. 
 
1.3.2 The spindle checkpoint in meiosis 
In meiosis, checkpoint proteins are present and are similarly recruited to unattached 
kinetochores (Sun & Kim 2012; Touati & Wassmann 2016). However, unlike in mitosis 
where a single unattached kinetochore is sufficient to prevent destruction of cyclin B1 (Lara-
Gonzalez et al. 2012), MI is characterised by a lengthy period of cyclin B1 destruction which 
initiates several hours ahead of metaphase, before chromosome alignment is achieved. 
Furthermore, this destruction initiates prior to stabilisation of kinetochore attachments and 
while checkpoint proteins remain on kinetochores (Kitajima et al. 2011; Gui & Homer 2012; 
Lane et al. 2012; Lane & Jones 2014). These data together suggest that while all the same 
checkpoint proteins appear to be present in oocytes as mitotic cells, somehow the response 
elicited is less efficient. This has been previously suggested to be due to the large volume of 
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an oocyte in which a diffusible checkpoint signal may become much weaker. In the following 
chapters, I will dispute that the situation is this simple and present an alternative model for 
cyclin B1 and securin destruction. 
While a number of studies have demonstrated that mouse oocytes with multiple attachment 
errors fail to block anaphase onset (LeMaire-Adkins et al. 1997; Yuan 2002; Hodges et al. 
2005; Nagaoka et al. 2011), all were carried out in genetically abnormal strains. Ordinarily 
mouse oocytes repair these attachment errors and the rate of aneuploidy (1-2%) is much lower 
than in human oocytes (20-25%) (Hook 1985; Hassold & Hunt 2001), this could be at least 
partially explained by the fact a human oocyte is 50% larger in diameter than a mouse oocyte 
(Griffin et al. 2006). However, pig oocytes that are only marginally smaller than human 
oocytes experience aneuploidy rates of around 10%, much higher than mouse oocytes yet still 
clearly much lower than the human error rates (Hornak et al. 2011). Pig oocytes have a 
spindle assembly mechanism that bears resemblance to that of both mice and humans; 
mediated by self-organising MTOCs yet also chromosome-dependent (Miyano et al. 2007). 
Perhaps a combination of a chromosome-dependent spindle assembly mechanism in humans 
that favours segregation errors (Holubcova et al. 2015), combined with an inefficient 
checkpoint over the large volume of an oocyte can begin to address the high error rates in 
human oocytes. 
Spindle assembly mechanisms, oocyte size and the ageing effect are all features of oocyte 
biology linked to the frequency of segregation defects in female meiosis, features vastly 
different to those presented by a normal mitosis. Since the same cell cycle proteins underpin 
and drive both meiotic and mitotic division, it seems reasonable to predict that the regulation 
of key cell cycle proteins will vary between mitosis and meiosis, adapted to a very different 
type of cell division. However, when compared to the depth and breadth of mitotic cell cycle 
studies, there are few independent, comparative cell cycle studies in mammalian female 
meiosis. In mouse oocytes, both cyclin B1 and securin are destroyed from late prometaphase 
while chromosomes are not aligned, yet this is not associated with an increase in divisional 
errors. From our understanding of how these proteins behave in mitosis, these observations 
are at complete odds with each other. In this thesis, I aim to expand upon our understanding 
of these key cell cycle mediators in mouse oocyte meiosis. 
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Chapter 2: Methods 
 
2.1 Mouse oocyte collection and culture 
Outbred four to eight week old female CD1 mice were purchased from Charles River and 
housed in the Comparative Biology Centre at Newcastle University. Germinal vesicle (GV) 
stage oocytes were collected from excised ovaries by shredding with a sterile 25-gauge 
needle. Cumulus cells were then mechanically stripped using hand pulled mouth pipettes, 
made by heating glass Pasteur pipettes over a Bunsen flame until soft. Pulling results in a 
fine, whisker-like shaft with an internal diameter just wider than that of an oocyte. All 
animals were handled in accordance with the ethics approved by the UK Home Office 
Animals (Scientific Procedures) Act 1986. For bench handling, microinjection and imaging 
experiments, oocytes were cultured on a heated stage at 37°C in M2 medium (Sigma) and 
where necessary, held in GV arrest until imaging by the addition of 30nM 3-isobutyl-1-
methyl xanthine (IBMX; Sigma). M2 medium also contained penicillin G (0.06g/l) and 
streptomycin sulphate (0.05g/l). Prior to imaging, oocytes were kept in petri dishes in small 
drops of M2 medium covered with embryo-tested mineral oil (Sigma) to prevent evaporation. 
When not being handled, petri dishes were covered with tin foil lids to prevent unnecessary 
light exposure. Only oocytes that underwent GVBD with normal timings and had a diameter 
within 95-105% of the population average were used. Where necessary and at the times 
indicated, nocodazole (Sigma) was added to the media at a concentration of 150 nM, and the 
Mps1 inhibitor reversine (Sigma) at 100 nM (Kolano et al. 2012). SiR Hoechst was added to 
media at 250 nM, 30 minutes prior to imaging (Lukinavičius et al. 2015). 
 
2.2 Plasmid constructs 
Wild-type human cyclin B1 (NM_031966), securin (NM_001282382) and cyclin A2 
(NM_001237) sequences were amplified from pre-existing gene targets within the lab. Wild-
type Cks1 (EF026652) was amplified from pWZL Neo Myr Flag CKS1B, a gift from William 
Hahn & Jean Zhao (Boehm et al. 2007) (Addgene plasmid # 20461). Amplified products were 
then subcloned using the SLIC technique (detailed in section 2.3) into MDL9; a modified 
pRN3 vector that contains a 5 amino acid C-terminal linker (AGAQF) to Venus Fluorescent 
Protein (VFP). All mutations were made as detailed in section 2.4. The Cdk1 FRET sensor 
(Addgene plasmid #26064; a gift from Jonathan Pines; Gavet & Pines 2010) and the separase 
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biosensor (a gift from Jan van Deursen; Nam & van Deursen 2014) were both amplified and 
cloned into pRN3 vectors.  
 
2.3 One-Step Sequence- and Ligation-Independent Cloning (SLIC) 
The MDL9 or pRN3 vector was linearized by incubation with BglII (Promega) for 3 hours at 
37 °C. The full digestion reaction was then run on a 1% agarose TAE w/EtBr gel. The 4kb 
digested vector was excised and extracted from the gel (GeneJET Gel Extraction Kit (Thermo 
Scientific)) and eluted in 10 mM Tris-HCl; pH 8.5. Inserts were amplified using primers 
designed to include a specific recognition site for BglII flanked on either side by a ≥15 bp 
extension homologous to the BglII-cut vector ends and a 10 bp insert-specific extension. This 
specifically creates 15 bp sequence length homologues to the vector. PCR reactions for SLIC 
were done using KOD polymerase (Merck), to give blunt-ended products. PCR products were 
then purified using a GeneJET PCR Purification Kit (Thermo Scientific), with elution in 10 
mM Tris-HCl, pH 8.5. Concentrations of both vector and insert were measured on a 
NanoDrop 2000 UV-Vis Spectrophotometer to calculate a 1:3 vector to insert molar ratio. 
Vector and insert were then combined along with H2O, BSA, NEB’s buffer 2 and T4 DNA 
Polymerase (0.4 µl) and incubated for 2.5 minutes in a 22 °C water bath. This reaction takes 
advantage of the 3’ to 5’ endonuclease activity of T4 DNA polymerase, creating the 
complementary overhangs with which the vector and insert will anneal during a 10 minute 
incubation period on ice. Following this, the plasmids were transformed into competent E. 
Coli cells (NovaBlue Singles competent cells (Novagen)) and plated on Agar containing 
ampicillin. SLIC was carried out according to the protocol in (Jeong et al. 2012). 
 
2.4 Mutagenesis by crossover PCR 
Mutations and linked constructs were generated using multi-round arm extension crossover 
PCR. The first round for any given mutation construct involved two separate, 30-cycle 
DreamTaq (Thermo Fisher) PCR reactions, reactions A and B. Reaction A used the normal 5’ 
SLIC primer designed as above with a 3’ primer designed with homology to 15 bp either side 
of the desired site of mutagenesis. The point changes mutations were included in the sequence 
of the primer arm. Reaction B was the reverse, a 5’ primer designed with homology to 15 bp 
either side of the site of mutagenesis, with the desired mutation in the primer sequence and a 
standard 3’ SLIC primer.  From reactions A and B, we get two PCR products, one running 
from the start of the sequence to 15 bp after the site of mutagenesis and one from 15 bp before 
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the site of mutagenesis to the end of the sequence, each containing the desired mutation. A 
third reaction is then carried out as a standard SLIC reaction, described in section 2.3, using 
only the 5’ and 3’ SLIC primers. However, rather than a wild-type gene template, instead the 
target is 0.5 µl of finished reaction A and 0.5 µl of finished reaction B. This allows for the 
homologous 30 bp mutation spanning regions of product A and B to anneal during the PCR 
reaction and assemble a full-length protein with the desired mutation. 
 
2.5 Sequencing 
Colonies selected from transformation plates were grown in LB broth in an oscillating (180 
rpm) 37 °C incubator overnight. Plasmid DNA was then isolated using a GeneJET Plasmid 
Miniprep Kit (Thermo Scientific) and quantified by a NanoDrop Spectrophotometer. 5 µl 
samples (100 ng/µl) were sent to Eurofins UK for sequence analysis. Returned sequences 
were checked via nucleotide BLAST search (http://www.ncbi.nlm.nih.gov) for accuracy 
before cRNA preparation. 
 
2.6 Preparation of cRNA and morpholino oligomers for microinjection 
cRNA for microinjection was prepared using a T3 mMESSAGE mMACHINE kit (Ambion 
Inc.). Following SLIC and sequence confirmation, approximately 1 µg of plasmid DNA was 
digested with SfiI for 5 hours at 50 °C. Once the reaction was complete, proteinase K was 
added for a final hour at 50 °C to remove any protein contamination. The reaction mix was 
then phenol/chloroform extracted, and followed by the addition of Pellet Paint (Merck) and 
1/10th volume of Na Acetate, pH 5.5, precipitated in 100% EtOH for >1 hour at -80 °C. The 
DNA pellet was then washed and resuspended in nuclease-free H20, all of which was used in 
a transcription reaction containing RNA polymerase enzyme mix, ribonucleotides and 
reaction buffer according to the manufacturer’s protocol. This reaction mix was incubated for 
2 hours at 37 °C, with addition of DNase for the final 15 minutes. Overnight lithium chloride 
precipitation at -20 °C followed by centrifugation extracted the cRNA from solution. The 
final cRNA pellet was then washed and resuspended in nuclease-free H20 and aliquots were 
stored at -20 °C for later use. Maximal stability was conferred on all cRNA constructs by the 
presence of a 5’ globin UTR upstream and both 3’ UTR and poly (A)-encoding tracts 
downstream of the gene. 
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Morpholino antisense oligomers (MO; Gene Tools) were used to knockdown gene expression. 
MOs were designed to recognize the 5’ UTR of APC3 and Cdc20. As per the manufacturer’s 
instructions, all MOs were stored at room temperature then heated for 5 minutes at 65 °C 
prior to use to resolubilise the oligos. MOs were then used at a micropipette concentration of 
1 mM. 
 
2.7 Microinjection and imaging 
Oocyte microinjection of MOs and cRNA constructs were carried out on the 37 °C heated 
stage (Intracel) of an inverted epifluorescence microscope (Olympus; 1X71) in a chamber 
containing 1 ml of M2 media covered with mineral oil to prevent evaporation. A pre-
fabricated holding pipette with a 30° bend (Hunter Scientific) was connected to a syringe 
(IM-5B, Narishige, Japan) filled with mineral oil, allowing for a fine hydraulically driven 
inward and outward flow of oil to position and hold oocytes during injection. The holding 
pipette was positioned centrally by eye to the base of the chamber using a three-way coarse 
manipulator (MMN-1, Narishige, Japan).  
Microinjection micropipettes were made from filamented borosilicate glass capillaries, outer 
diameter of 1.5 mm and inner diameter of 0.86 mm (Harvard Apparatus Ltd.). Microinjection 
needles were made using a micropipette puller (Model P-97, Sutter Instruments, California, 
USA). Freshly pulled needles were then broken by gently brushing through cotton wool and 
checked for size and suitability using a bench top stereomicroscope (Nikon Optiphot Pol) at 
10x magnification. 
Microinjection pipettes were then loaded with cRNA or MO using a glass Microliter syringe 
(Hamilton) and microloader tip (Eppendorf). Loaded microinjection pipettes were fitted into a 
microelectrode holder prefilled with 120 mM KCl in 10 mM HEPES, pH 7.4 and connected 
to an electrometer (Electro 705, World Precision Instruments). The microelectrode holder was 
attached to a Pneumatic PicoPump (PV830, World Precision Instruments) via plastic tubing. 
This apparatus was manipulated using both a three-way coarse manipulator (MMN-1, 
Narishige, Japan) and a three-axis oil hydraulic micromanipulator (MMO-203, Narishige, 
Japan). Micropipettes were positioned just above the egg and then pushed through the zona 
pellucida. A brief pulse of negative capacitance overcompensation provided by the ‘Tickler’ 
function on the Electro 705 electrometer provides a momentary oscillation assisting passage 
into the oolemma. The cRNA or MO was then injected by a brief pulse of compressed air to 
the back of the micropipette provided by the Pneumatic PicoPump. This procedure ensures a 
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high rate of survival, typically >90%. The final volume of injection was estimated by the 
diameter of displaced ooplasm and was typically between 0.1-0.3% of total volume. 
Images were captured on an Olympus IX71 inverted epifluorescence microscope using a CCD 
camera (Micromax, Sony Interline chip, Princeton Instruments) and analysed using MetaFluor 
software (Molecular Devices). All experiments were performed at 37 °C. To generate the 
resulting fluorescent protein profiles, bright-field and fluorescence images were recorded at 
10 minute intervals.  
 
2.8 Confocal microscopy of separase biosensor 
Separase biosensor-injected oocytes were imaged on a Nikon A1R confocal laser microscope. 
Imaging began at 5 hours post GVBD to minimise oocyte laser exposure. Oocytes were 
imaged at 10 minute intervals over a 6 hour period in a temperature-controlled, humidified 
chamber set at 37 °C. Bright-field and fluorescent images were recorded in NIS-Elements 
(Nikon) and processed in Fiji (Schindelin et al. 2012). All oocytes extruded polar bodies. 
 
2.9 Western blots 
Mitotic U2OS cells and MEFs were prepared by lysis in Laemmli buffer following 
mechanical shake off of metaphase cells after an 8 hour incubation in 100 nM nocodazole. 
Oocytes were collected 5.5 hours after GVBD ± 15 min and lysed in Laemmli buffer. The 
cyclin B1:Cdk1 purified complex was purchased from Thermo Fisher Scientific; PV3292. 
Protein samples were boiled for 5 minutes at 95 °C, loaded into the wells of a Bis-Tris 
NuPAGE gel (Thermo Fisher), then fractioned at 180 V for 1 hour in an XCell SureLock 
Mini-Cell Electrophoresis tank (Invitrogen) attached to a PowerPac HC High Current power 
supply (BioRad). Gels were run in MOPS running buffer (Thermo Fisher). A multicolour 
protein ladder (Spectra, Thermo Fisher) was loaded into the first lane as a size marker. 
Following electrophoresis, gels were removed from casing and transferred onto a 
polyvinylidene fluoride (PVDF) membrane at 30 V overnight in a Mini Trans-Blot tank (Bio-
Rad) attached to a PowerPac HC High Current power supply (BioRad). Transfer buffer 
contained 25mM Tris buffer, 192mM glycine, 20% methanol. PVDF membrane required pre-
wetting in methanol for 30 seconds followed by incubation for 10 minutes in transfer buffer. 
Following transfer, membranes were blocked in 5% non-fat dry milk (Bio-Rad) in phosphate 
buffered saline 0.05% Tween 20 (PBST) for 1 hour at room temperature before addition of 
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primary antibodies. For cyclin B1, immunoblots were incubated at RT for 2 hours with anti-
cyclin B1 (Abcam ab72) at 1:250. For Cdk1, immunoblots were incubated at RT for 2 hours 
with anti-Cdk1/Cdk2 (Santa Cruz sc-53219) at 1:200. After the overnight incubation, 
membranes were washed in PBST (3 x 10 minutes changing wash solution in between) then 
incubated with anti–mouse IgG (7076P2; Cell Signalling) horseradish peroxidase (HRP)-
linked secondary antibody for 1 hour at RT in 2.5% non-fat dry milk in PBST. Membranes 
were given a final wash step in PBST (2 x 10 minutes) followed by a 10 minute wash in 
phosphate buffered saline (PBS) before a 5 minute incubation in ECL Select (RPN2132; GE 
Healthcare) to detect protein-bound HRP-labelled secondary antibodies. Membranes were 
then exposed to Hyperfilm x-ray film (Amersham Biosciences) and developed using a 
SRX101 film processor (Konica). The exposure time depended on the strength of the signal. 
 
2.10 Data analysis 
Real-time destruction profiles were recorded in MetaFluor (Molecular Devices) and data was 
automatically logged in Excel. By taking an average VFP intensity reading from a defined 
region of interest around the oocyte, these were plotted over time and aligned at PB1 
extrusion unless otherwise stated. Average cleavage profiles for separase biosensor 
experiments were produced in Fiji (Schindelin et al. 2012) by first creating a clipping mask to 
the DNA using the far red signal from Sir Hoechst treatment. The GFP and mCherry intensity 
readings from the clipping mask were then plotted over time and aligned at PB1 extrusion and 
the GFP/RFP ratio was calculated. Statistics were exported from MetaFluor and Fiji into 
Excel (version 14.4.8, Microsoft) where all destruction traces were produced. Typically when 
only two constructs were being compared, both the average traces and individual traces were 
shown, whereas when 3 or more constructs were being compared, for clarity, only the average 
traces are shown but with error bars = +/- SEM. 
 
2.11 Other techniques 
Molecular structure images were generated using the PyMOL Molecular Graphics System, 
version 1.3 Schrödinger, LLC. Sequence conservation alignments were made by importing 
protein sequences from Uniprot and aligning in Jalview, version 15.0, (Waterhouse et al. 
2009). All figures were prepared in Adobe Illustrator CC, version 17.1.0.  
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Chapter 3: A second destruction motif in the N-terminal helix of 
cyclin B1 mediates late prometaphase destruction in mouse 
oocytes. 
 
3.1 Introduction 
Cdk1 is the only cyclin-dependent kinase that is essential to the eukaryotic cell cycle 
(Santamaría et al. 2007). Throughout early mitosis, Cdk1 is activated by its binding partner 
cyclin B1. Cyclin B1 must be maintained at a level sufficient to generate enough cyclin 
B1:Cdk1 activity (“Cdk1 activity”) to drive the early stages of cell division (Gavet & Pines 
2010). By monitoring the status of kinetochore microtubule attachments, spindle checkpoint 
proteins safeguard cyclin B1 levels, preventing its destruction, thereby inhibiting anaphase 
until all chromosomes have congressed and their kinetochores have established stable 
attachments (Lara-Gonzalez et al. 2012). Thereafter, a sharp drop in Cdk1 activity via cyclin 
B1 destruction is equally important to drive the events of anaphase and cytokinesis (Sullivan 
& Morgan 2007). 
The goal of the spindle checkpoint is to attenuate the activity of the anaphase promoting 
complex or cyclosome (APC/C), an E3 ubiquitin ligase which directs the degradation of a 
number of cell cycle proteins. To ensure accurate passage through all stages of chromosome 
alignment and segregation, the APC/C must process its substrates in strict order, an order 
largely achieved via distinct substrate degradation motifs. The most common of these motifs 
is the classic destruction motif, the D-Box, that directs cyclin B1 destruction in metaphase 
(Glotzer et al. 1991).  
In the absence of checkpoint activity, the APC/C and its co-activator Cdc20 form a bipartite 
co-receptor for D-Box docking (He et al. 2013). This allows cyclin B1 to be ubiquitinated on 
several lysine residues and to be delivered to the 26S proteasome-mediated degradation 
(Yamano et al. 1998). Prior to chromosome alignment, each unattached kinetochore generates 
a checkpoint signal which is sufficient to prevent Cdc20 from binding to the D-box of 
metaphase substrates (Lara-Gonzalez et al. 2012). Chromosome misalignment in mitosis 
therefore strongly inhibits cyclin B1 destruction to prevent premature chromosome 
segregation and the possibility of aneuploid daughter cells. Metaphase then coincides with the 
initiation of cyclin B1 destruction. 
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Female mammalian meiosis is also driven by Cdk1 activity (Ledan et al. 2001) and governed 
by the same checkpoint as mitosis (Gorbsky 2015). Yet, unlike mitosis, meiosis I (MI) is 
characterised by a lengthy period of cyclin B1 destruction which initiates several hours ahead 
of metaphase, before chromosome alignment is achieved, prior to the stabilisation of 
kinetochore attachments, and while checkpoint proteins remain on kinetochores (Brunet et al. 
1999; Davydenko et al. 2013; Gui & Homer 2012; Kitajima et al. 2011; Lane et al. 2012; 
Lane & Jones 2014; Nagaoka et al. 2011; Sebestova et al. 2012). Indeed, at the initiation of 
cyclin B1 destruction, nearly half of all mouse oocytes have chromosomes not located near 
the spindle equator (Lane et al. 2012). 
Surprisingly however, during this prolonged period of cyclin B1 destruction, the vast majority 
of mouse oocytes continue to perfect chromosome alignment and undergo a division which 
produces a euploid egg. Indeed the rate of aneuploidy observed in fertilised mouse eggs is 
only 1-2% (Bond & Chandley 1983), a figure far lower than the estimated error rate of 20-
25% in human eggs (Hassold & Hunt 2001). A key puzzle, therefore, is how cyclin B1 evades 
the spindle checkpoint in mouse oocytes, and why the early loss of cyclin B1 does not 
negatively impact oocyte competency. 
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3.2 Results 
3.2.1 Cyclin B1 levels are in excess and do not report Cdk1 activity in MI 
mouse oocytes. 
In contrast to mitotic cells where Cdk1 protein levels are in excess of cyclin B1, we find that 
this balance is reversed in prometaphase I mouse oocytes, a finding also reported in prophase 
I mouse oocytes (Kanatsu-Shinohara et al. 2000). Mass amounts of cyclin B1 and Cdk1 
protein were initially determined in a range of known numbers of mitotically enriched U2OS 
cells by immunoblotting alongside known masses of a purified cyclin B1:Cdk1 complex (Fig. 
3.1A-C). The average mass of cyclin B1 and Cdk1 per 1000 U2OS cells was calculated to be 
0.68ng and 0.4ng respectively. Using molecular weights based on the amino acid sequences, 
molar masses were calculated demonstrating the molar ratio of cyclin B1:Cdk1 in mitotically 
enriched U20S to be approximately 1:1. 
Mass amounts of cyclin B1 and Cdk1 protein were then determined in late prometaphase I 
oocytes (5.5 hours post GVBD) by immunoblotting alongside a range of known numbers of 
U2OS cells (Fig. 3.1D-E). The average mass of cyclin B1 per single oocyte was calculated to 
be equal to that of 16.3 U2OS cells or 11.09 pg. The average mass of Cdk1 per single oocyte 
was calculated to be equal to 2.7 U2OS cells or 1.09 pg. Molar amounts were then 
determined, generating a ratio of approximately 6:1 cyclin B1:Cdk1 in late prometaphase I 
mouse oocytes. Interestingly in mouse embryonic fibroblasts (MEFs), Cdk1 is once again in 
excess (Fig. 3.1D). This suggests the cyclin B1 excess observed in meiosis is quickly lost by 
early mitotic divisions. Consequently, though exogenous fluorescently-tagged cyclin B1 
reports changes in Cdk1 activity during mitosis (as confirmed by a Cdk1 activity FRET 
biosensor (Gavet & Pines 2010)), we reasoned that early cyclin B1 destruction in mouse 
oocytes might instead reflect the proteolysis of free cyclin B1 rather than Cdk1-bound cyclin 
B1.  
Mouse oocytes were microinjected with cRNA encoding the Cdk1 FRET biosensor then 
imaged at 10 minute intervals from prophase to anaphase I. Average fluorescence intensity 
readings were taken from a defined region of interest around each oocyte, plotted over time 
and aligned using the first polar body (PB1) extrusion as a reference point.  
Indeed, after validating the Cdk1 FRET biosensor for its use in oocytes, we find that Cdk1 
activity is stable during the first ~1.5 hours of cyclin B1 destruction, only declining in the 
final hour before polar body (PB1) extrusion (Fig. 3.2C). Fluorescent cyclin B1 levels  
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Figure 3.1. Quantification of cyclin B1 and CDK1 in mouse oocytes 5.5 h post GVBD using 
a 1:1 cyclin B1:CDK1 protein complex. (A) Western blot of known amounts of cyclin B1 and 
CDK1 recombinant protein (purified complex) alongside known numbers of mitotic U2OS cells 
to quantify cyclin B1 and CDK1 protein bands in U2OS cells (cell numbers indicated above). (B) 
Band densities of ‘purified complex’ lanes in part ‘A’ plotted relative to protein amount in ng. (C) 
Calculated amounts of cyclin B1 and CDK1 in 1000 U2OS cells using U2OS lane band densities 
in part ‘A’ and the equation of the line generated in part ‘B’. (D) Western blot of mitotic mouse 
embryonic fibroblasts (MEFs), U2OS cells, oocytes collected 5.5 hours post GVBD and 1.5 ng of 
cyclin B1 + 1.5 ng of CDK1 recombinant protein (cell numbers indicated above). Note the 
difference in the balance of cyclin B1 and CDK1 in the mitotic cycles of MEFs, here CDK1 is in 
excess. (E) Using the same strategy as in ‘B’ and ‘C’, cyclin B1 and CDK1 band densities from 
part ‘D’ were used to relate cyclin B1 and CDK1 protein levels in oocytes to an equivalent 
number of U2OS cells. From this cyclin B1 and CDK1 protein amounts were calculated per 
oocyte. We calculate the ratio of cyclin B1:CDK1 to be approximately 6:1. 
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Figure 3.2. Cyclin B1 levels do not reflect CDK1 activity in MI mouse oocytes. (A) MI spindle 
assembly, chromosome alignment and PB1 extrusion. Homologous chromosome pairs (blue) align on 
the spindle apparatus (green). (B) Stages of MI based on the timing of cyclin B1 destruction. Spindle 
checkpoint activity (red bar), prometaphase (yellow bar) and metaphase (blue bar) are shown. (C) 
Levels of cyclin B1-Venus (blue trace, n=16 oocytes, means ± SEM) alongside CDK1 activity deter-
mined using a FRET biosensor (green trace, n=72). Retimed stages of MI based on the time of CDK1 
activity loss are also shown (colours as in B). 
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therefore misinform our view of MI progression. If prometaphase and metaphase are timed in 
relation to the loss of Cdk1 activity (Fig. 4.2C), rather than the initiation of cyclin B1 
degradation (Fig. 3.2B), a clear picture of MI emerges. Metaphase, during which Cdk1 
activity declines, now coincides with the time at which stable end-on kinetochore-microtubule 
attachments are formed and checkpoint proteins are maximally depleted from kinetochores 
(Kitajima et al. 2011; Lane et al. 2012). However, this does not explain why cyclin B1 levels 
decline in prometaphase. 
 
3.2.2 D-box only recognition is not sufficient for a normal cyclin B1 
destruction profile in mouse oocyte meiosis. 
Given that, in oocytes, two pools of cyclin B1 exist (Cdk1-bound and non-Cdk1-bound), and 
that the majority of cyclin B1 is lost before a decline in Cdk1 activity, we wanted to 
determine whether free cyclin B1 is destroyed in preference to Cdk1-bound cyclin B1. 
Initially we tested two fluorescent cyclin B1 reporters, a Y170A mutant of full-length cyclin 
B1 unable to bind to Cdk1 (Y170A; Bentley et al 2007) and the N-terminal 90 amino acids of 
cyclin B1 (N90; Fig. 3.3A) . Y170A was used as a marker to represent free cyclin B1 while 
N90 was used to represent the tail of cyclin B1 that remains accessible when the protein is in 
complex with Cdk1 (Brown et al. 2015).  Both constructs contain the D-box sequence and 
neighbouring lysine residues known to be necessary and sufficient for recognition by APC/C-
Cdc20 and subsequent proteolysis in mitosis (Pines 2011; Yamano et al. 1998), however N90 
critically lacks other well conserved regions of the protein, namely the N-terminal helix and 
cyclin box/fold regions of the protein.  
When cRNA encoding these proteins is microinjected into oocytes we find that while the 
destruction profile of Y170A is similar to that of wild-type (WT) cyclin B1, N90 is not 
destroyed until much later (~80 minutes) and concurrently with the loss of Cdk1 activity (Fig. 
3.3B). The difference seen in protein destruction kinetics is not an artefact of contrasting 
levels of exogenous protein or as a result of differences in translation efficiency. 
Overexpression levels are matched for each protein and no higher than 15% endogenous. 
Furthermore, the use of cycloheximide (CHX) to block translation does not change the order 
of destruction (data not shown). This raises the possibility that an additional binding motif or 
degron exists in cyclin B1 between residues 90-433, which promotes its earlier degradation. 
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Figure 3.3. D-box only recognition is not sufficient for a normal cyclin B1 destruction 
profile.  (A) Schematic of Venus-tagged cyclin B1 Y170A, a non-CDK1-binding mutant and 
cyclin B1 N90 constructs. (B) Levels of Venus-tagged cyclin B1 Y170A (n=32) and cyclin B1 
N90 (n=34) alongside CDK1 activity (n=72, secondary axis) during MI. (C) Levels of 
Venus-tagged cyclin B1 Y170 (n=32); N90 (n=34); N167 (n=38) and N190 (n=38) during MI. 
Traces are aligned to the first polar body extrusion (PB1). Error bars = SEM throughout.
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3.2.3 A second destruction motif exists within the N-terminal helix (NTH) of 
cyclin B1. 
To test if a second destruction motif exists within cyclin B1, one that facilitates its 
prometaphase destruction, we made the following stepwise extensions to the C-terminus of 
N90; N146, N167 and N190. We found that a destruction profile resembling that of full-
length Y170A was recovered between residues 167 and 190 (Fig. 3.3C). Between residues 
167 and 190 lies the N-terminal helix (NTH) of cyclin B1 (residues 170-196, Fig. 3.4D), an 
integral part of the Cdk1 binding interface (Brown et al. 2015). Coupling the NTH to N90 
(N90+NTH) is sufficient to convert N90 from a late substrate to a much earlier WT-like 
destruction target (Fig. 3.4B), thus confirming that the region required for early degradation 
lies completely within the NTH.  
Alanine mutagenesis of Y170A revealed residues within the NTH that are essential for early 
cyclin B1 destruction (only the final mutant is shown; figs 3.4A and 3.4C). We suggest that 7 
residues, DIY (173-175) and LRQL (178-181), constitute a novel motif (hereafter named the 
PM-motif) able to direct APC/C-mediated proteolysis of free cyclin B1 in late prometaphase. 
Indeed, a PM motif mutant lacking these 7 residues (Y170A lacking the PM motif), B1 PM 
mutant is destroyed over the same late time period as N90 (Figs 3.4C and 3.4E). Again this 
order of destruction is maintained where Y170A and PM mutant expressing oocytes are 
matured in the presence of CHX. 
 
3.2.4 Masking of the NTH region of cyclin B1 on Cdk1 binding. 
The crystal structure of the human cyclin B1:Cdk1 in complex with Cks2 (Brown et al. 2015) 
supports our hypothesis that the PM motif would be masked when cyclin B1 is bound to 
Cdk1. The NTH forms a crucial part of the interaction, sitting deep in the interface between 
cyclin B1 and Cdk1 (Fig. 3.5A), making it likely that Cdk1 binding would obscure the PM-
motif, leaving only the D-box of cyclin B1 accessible. We propose the following model; 
unbound excess cyclin B1 is targeted preferentially in late prometaphase via its PM motif; 
Cdk1-bound cyclin B1 is then destroyed later, in metaphase, via its D-box, thus protecting 
Cdk1 activity. 
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Figure 3.4. A second destruction motif exists within the NTH of cyclin B1. (A) NTH sequence 
detail. WT, Y170A and PM mutant (B1 PMmut) sequences are shown. (B) Destruction profiles of 
B1 N90+NTH (yellow, n=22) and B1 N90 (pink, n=34). (C) B1 N90, Y170A and PM mut destruc-
tion profiles. (D) Sequence alignment of NTH-containing region in cyclin B1 orthologs.  (E) 
Destruction of Venus tagged cyclin B1 truncations and mutants. Other than wild type cyclin B1 (B1 
WT), all lack the ability to bind CDK1 and therefore act as reporters of destruction timing without 
perturbing endogenous CDK1 activity. Schematic representations of cyclin B1 constructs are 
shown down the right hand side (cyclin box / fold not to scale) while the bars to the left indicate 
destruction timings. The length of each bar indicates the number of minutes ahead of the minimum 
fluorescence/maximum destruction point (time 0). The open, white bars indicate the point at which 
75% of the destruction has taken place. The light blue extension to this bar indicates the point at 
which 50% of the destruction has taken place (error bars = SEM), followed by a dark blue exten-
sion indicating the point at which 25% of the destruction has taken place. Similarly, CDK1 activity 
loss, as measured via FRET, is shown in green. The period over which PB1 extrusions occur is 
shaded in grey.  
E.
Time in minutes prior to cyclin B1 minimum
D-box NTH Cyclin box /
 fold
020406080100120
 B1 WT
CDK
N90
N167
N190
N90+NTH
B1 PM mut
B1 Y170A
PB1
75% loss50% loss25% loss
26
N
D-box
Cyclin B1
CDK1
B.
B1
B1 CDK1
B1
B1
B1
B1
B1
B1 CDK1
Prometaphase
Spindle checkpoint activity 
Metaphase
APC activity 
A.
Figure 3.5. Masking of the NTH region of cyclin B1 on CDK1 binding. (A) Surface representa-
tion of cyclin B1:CDK1 from the crystal structure of its complex with CKS2 (Brown et al., 2015) 
(pdb accession 4Y72). The NTH and preceding loop are excluded from the surface and their back-
bones are instead shown, with residues 173-DIY-175 and 178-LRQL-181 highlighted in red. The 
flexible N-terminal extension harbouring the D-box is illustrated.  (B) Model of cyclin B1 degrada-
tion in mouse oocytes as spindle checkpoint activity declines and APC/C-Cdc20 activity increases. 
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3.3 Discussion 
An estimated 20-25% of human oocytes missegregate their chromosomes, making aneuploidy 
the number one genetic cause of miscarriages and birth defects (Hassold & Hunt 2001). 80-
90% of these segregation errors are thought to occur in MI (Homer 2011). The seemingly 
precocious destruction of cyclin B1 observed in mouse oocyte MI has previously been 
suggested to contribute to aneuploidy and evidence of an oocyte-specific defect in the spindle 
checkpoint which allows the cell cycle to proceed despite chromosome alignment errors. 
However, mouse oocytes are rarely aneuploid. Misaligned chromosome pairs are a common 
feature of mouse oocytes during the initial period of cyclin B1 destruction, yet almost all 
achieve biorientation before anaphase onset (Lane et al. 2012). Mouse oocytes continue to 
perfect chromosome alignment and undergo a division yielding a euploid egg. It therefore 
became of primary interest how cyclin B1is able to bypass the spindle checkpoint in mouse 
oocytes, and why its early degradation does not negatively affect oocyte competency. 
In stark contrast to the situation in mitosis in which Cdk1 is present in excess over cyclin B1 
(Arooz et al. 2000), we show that in oocytes it is instead cyclin B1 that is present in large 
excess. By quantifying the ratio of cyclin B1:Cdk1 in prometaphase I mouse oocytes we find 
cyclin B1 to be approximately 6-fold in excess of Cdk1. This excess of cyclin B1 is lost by 
early mitotic divisions, evident in the dramatic switch back to a large Cdk1 excess observed in 
early embryonic mitosis (MEFs). This therefore suggests a meiosis specific translation 
program that generates a large excess of cyclin B1. How cyclin B1:Cdk1 ratio evolves 
through MII and the first embryonic divisions remains a point of future interest. 
What is clear is that early cyclin B1 degradation is not associated with a decrease in Cdk1 
activity; Cdk1 activity is instead preserved until the final hour before PB1 extrusion. This late 
drop in Cdk1 activity coincides with timings for maximal removal of checkpoint proteins 
from the kinetochore and the formation of stable end-on kinetochore microtubule attachments 
(Kitajima et al. 2011; Lane et al. 2012). We therefore suggest that early destruction represents 
that of an excess pool of free cyclin B1 whose degradation will not directly compromise Cdk1 
activity.  
To address how free cyclin B1 could evade an active checkpoint in late prometaphase while 
Cdk1-bound cyclin B1 was protected, we used reporters for free and Cdk1-bound cyclin B1. 
We show that an N-terminal truncation (N90) of cyclin B1, representing the tail region of 
cyclin B1 that remains accessible on Cdk1 binding, was targeted for degradation much later 
than a full length non-Cdk1-binding cyclin B1, in time with a drop in Cdk1 activity. Critically 
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the truncated construct contains the D-box and neighbouring lysine residues previously shown 
to be necessary and sufficient for degradation in mitosis (Glotzer et al. 1991). This raised the 
possibility that, similar to other APC/C substrates such as cyclin A2, an additional sequence 
exists between residues 90-433 which functions to promote degradation in the presence of an 
active checkpoint (Di Fiore et al. 2015).   
After multiple rounds of serial truncation and point mutation we arrived at a discrete motif in 
the N-terminal helix (centred around residues 173DIY175 and 178LRQL181). We have named this 
motif the PM motif due to its ability to direct Pro Metaphase destruction. Mutating this motif 
delays cyclin B1 degradation until the metaphase drop in Cdk1 activity. Pinpointing the PM-
motif to within the NTH suggests how the cellular destruction machinery is able to 
discriminate between Cdk1-bound and free cyclin B1. Excess free cyclin B1 is targeted via its 
D-box and PM-motif, both of which are essential for timely degradation when the checkpoint 
is still active in prometaphase. In contrast, Cdk1 binding obscures the PM-motif, leaving only 
the D-box of cyclin B1 accessible. This protects a proportion of cyclin B1 and maintains 
Cdk1 activity until the checkpoint is satisfied in metaphase (see Fig. 3.5B for model); the 
availability of the PM motif grants APC/C preferential targeting of non-Cdk1-bound cyclin 
B1 in situations where chromosomes have not yet achieved full alignment. We suggest that in 
mouse oocytes, PM-motif-mediated destruction of free cyclin B1 may couple the timing of a 
prolonged late prometaphase to the progressive positioning of chromosomes.  
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Chapter 4: A hidden motif in securin mediates late prometaphase 
destruction in mouse oocytes 
 
4.1 Introduction 
Mitosis 
Successful cell division relies on chromosomes first organising and correctly aligning on the 
spindle followed by the separation of sister chromatids into two genetically identical sets of 
chromatids, an event tightly coordinated with metaphase exit. Two key events within the cell 
are critical to this process. Firstly, the removal of Cdk1 activity via cyclin B1 degradation 
(discussed in Chapter 3) which initiates a cascade of Cdk1 substrate dephosphorylations 
(Sullivan & Morgan 2007), and secondly degradation of securin allowing for separase 
activation (Ciosk et al. 1998; Uhlmann et al. 1999). If these events become disconnected, as 
demonstrated by artificial stabilisation of Cdk1 activity during normal separase activity, 
anaphase becomes extremely problematic with cells unable to form stable kinetochore 
microtubule attachments (Kamenz & Hauf 2014; Rattani et al. 2014). 
In order to prevent precocious separation of sister chromatids, separase must be kept inactive 
state until a time when all chromosomes are correctly orientated on the spindle.  Prior to 
anaphase, separase is kept inactive via a number of intricate mechanisms. Firstly, separase is 
inhibited by its binding partner securin which is present in excess of separase in mitotic cells 
(Hellmuth et al. 2014; Kamenz et al. 2015). Human securin is a relatively short and 
unstructured protein that binds across the surface of separase, acting as a pseudo substrate by 
occupying the Scc1 recognition site (Sánchez-Puig et al. 2005; Nagao & Yanagida 2006; Lin 
et al. 2016). Not only does securin function to inhibit separase, it also has an activating role. 
Separase is less active and less stable before it complexes with securin, than it is once 
released from securin, thereby preventing premature proteolytic activity prior to securin 
binding (Holland & Taylor 2008). 
While in a typical eukaryotic cell most separase is inhibited by securin, cyclin B1-Cdk1 has 
also been shown to have the capacity to bind and inhibit separase (Stemmann et al. 2001; 
Gorr et al. 2005), likely able to completely take over this role given that securin is dispensable 
in mice (Mei et al. 2001; Wang et al. 2001). Phosphorylation of serine residue S1126 of 
separase by Cdk1 provides a platform for Pin1, a mitotic peptidyl-prolyl isomerise, to bind. 
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Pin1 then isomerises the bond between the phosphorylated serine and its adjacent proline 
residue (Hellmuth et al. 2015). This both renders separase more prone to aggregation and 
allows cyclin B1-Cdk1 to bind and inhibit separase (Hellmuth et al. 2015). In vertebrate cells, 
this inhibition is mutual, with separase having an inhibitory effect on cyclin B1-Cdk1. Where 
securin is the chief separase inhibitor, once separase is liberated and isomerised by Pin1, 
residual cyclin B1-Cdk1 is seen to complex with active separase. Abolishing cyclin B1 
binding to separase by mutating a key serine residue (S1121) in separase results in 
segregation errors that are rescued by Cdk1 inhibition (Shindo et al. 2012). Correct polar body 
extrusion in mouse oocytes has also been shown to be dependent on Cdk1 inhibition by 
separase (Gorr et al. 2006). Whether separase is inhibited primarily by securin or by cyclin 
B1-Cdk1 varies depending on cell type and developmental state. Primordial germ cells and 
early stage embryos rely primarily on cyclin B1-Cdk1-mediated inhibition, whereas in female 
mouse meiosis II, human cancer cells and healthy human mitotic cells, securin is largely 
responsible for separase inhibition (Nabti et al. 2008; Huang et al. 2009; Kamenz & Hauf 
2017). 
Upon accurate chromosome alignment and termination of the spindle checkpoint, the APC/C 
in conjunction with its co-activator Cdc20 targets securin and cyclin B1 via their D-box 
motifs for ubiquitination and subsequent proteasomal degradation (Yamano et al. 1998; 
Hagting et al. 2002). Unlike cyclin B1, securin also contains a KEN box (residues 9-11) in 
addition to its destruction box. Since the KEN box can be targeted by the APC/C and its 
anaphase co-activator Cdh1, KEN box recognition is thought to take place much later in 
mitosis when the APC/C switches from Cdc20 to Cdh1 co-activation (Pfleger & Kirschner 
2000). Where in mitosis a D-box mutation in cyclin B1 renders it non-degradable (Glotzer et 
al. 1991), securin with a mutated D-box but an intact KEN box is still degradable, however its 
destruction is delayed until anaphase when the APC/C switches from Cdc20 to Cdh1 co-
activation (Hagting et al. 2002). APC/C-mediated securin destruction releases the inhibitory 
hold on separase which in turn cleaves the kleisin subunit of the cohesin ring structure which 
holds sister chromatids together during metaphase (Uhlmann et al. 1999). Together separase 
activity and Cdk1 inactivation due to cyclin B1 destruction drive anaphase and mitotic exit. 
Securin destruction in mitosis begins at metaphase, once the spindle checkpoint is satisfied 
and mirrors that of cyclin B1, with degradation of both proteins required before sister 
chromatids can properly separate (Hagting et al. 2002). 
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Meiosis 
Like mitosis, securin is known to be targeted for destruction in time with cyclin B1 in mouse 
oocytes (Homer et al. 2005). Unlike mitosis, this is at a time when checkpoint proteins are 
still detectable at the kinetochore (Lane et al. 2012). Beyond this, very little is known about 
securin destruction and separase inhibition in meiosis I. How and why securin is degraded 
throughout late prometaphase I is unknown. The similarities in degradation timings and 
APC/C recognition of cyclin B1 and securin, their overlapping roles in mitosis and the critical 
need for the synchronous loss of both proteins made it a primary line of interest to further 
investigate securin in meiosis. Specifically, whether securin exhibits a similar biphasic pattern 
of destruction to that of cyclin B1 in mouse oocytes.  
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4.2 Results 
4.2.1 The D-box of securin is not sufficient for a wild-type (WT) destruction 
profile in MI mouse oocytes. 
Given that securin is targeted for degradation in time with cyclin B1 in oocytes (Homer et al. 
2005), I wanted to determine whether securin also showed a biphasic destruction profile 
similar to that of cyclin B1 (Levasseur et al. 2017 unpublished). Furthermore, I wanted 
investigate whether late prometaphase I destruction of securin was similarly mediated by a 
second destruction box working alongside the D-box. 
Employing a strategy similar to that of the cyclin B1 PM motif discovery, two fluorescent 
securin reporters were initially tested, full-length securin (securin FL) and the N-terminal 101 
residues of securin (securin N101). Both constructs contain the KEN box, D-box and 
neighbouring lysine residues necessary for APC/C recognition and subsequent proteolysis 
(Zur & Brandeis 2001; Hagting et al. 2002), however N101 critically lacks highly conserved 
regions within the C-terminal half of the protein (Fig. 4.1A).  
Mouse oocytes were microinjected with cRNA encoding the securin VFP construct of interest 
then imaged at 10 minute intervals from prophase I to anaphase I. Average fluorescence 
intensity readings were taken from a defined region of interest around each oocyte, plotted 
over time and aligned using first polar body (PB1) extrusion as a reference point.  
Securin FL was consistently targeted for destruction much earlier (~80 minutes) than securin 
N101 (Fig. 4.1B). When these destruction profiles were combined with data from our cyclin 
B1 study, it was revealed that not only were securin FL and cyclin B1 FL targeted for 
degradation simultaneously, securin N101 was degraded in time with cyclin B1 N90 (which 
contains the D-box and neighbouring lysine residues but critically lacks the PM motif that 
mediates late prometaphase I destruction) and concurrently with the loss of Cdk1 activity 
(Fig. 4.1C). This raises the possibility that, similar to cyclin B1 and other APC/C substrates 
such as cyclin A2, an additional sequence in the C-terminus of securin may cooperate with the 
D-box to direct APC/C-mediated degradation during prometaphase I in oocytes. 
 
4.2.2 A second destruction motif exists within the C-terminus of securin. 
To test if a second destruction motif exists within securin, one that facilitates its prometaphase 
destruction, a number of stepwise extensions were made to the C-terminus of securin N101.  
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Figure 4.1. D-box only recognition is not sufficient for a normal securin destruction profile in 
MI mouse oocytes. (A) Schematic showing VFP-tagged securin truncations and mutations. (B) 
Average securin FL::VFP (orange, n=25) and securin N101::VFP (blue, n=23) destruction traces 
aligned at PB1 extrusion. (C) Average securin FL::VFP (orange, n=25), securin N101::VFP (blue, 
n=23), cyclin B1 FL::VFP (orange dotted, n=32) and cyclin B1 N90::VFP (blue dotted, n=34) 
destruction profiles alongside CDK1 activity (n=72, secondary axis) during MI aligned at PB1 
extrusion. (D) Average securin FL::VFP (orange, n=25), securin N159::VFP (red, n=23), securin 
N133::VFP (purple, n=22) and securin N101::VFP (blue, n=23) destruction profiles aligned at PB1 
extrusion. (E) Average securin FL::VFP (orange, n=25), securin N101::VFP (blue, n=23) and securin 
Δ109-133 (yellow, n=23) destruction profiles aligned at PB1 extrusion. Error bars = +/- SEM.
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Initial extension constructs were securin N133 and N159, two extensions of securin N101 that 
separated regions of high conservation within the protein. Securin N159 was targeted for 
destruction in time with securin FL whereas securin N133 was targeted for destruction 
approximately 50 minutes after this (Fig. 4.1D). However, when residues 109-133 were 
replaced with a neutral linker in a full-length securin construct (securin Δ109-133), it was 
then targeted in time with securin N101 (Fig. 4.1E). To fully mimic wild-type destruction, it 
appears that a region within residues 109-133 is essential for prometaphase targeting of 
securin in meiosis, alongside additional information present between residues 133-159. 
To narrow down the residues important in mediating prometaphase I securin destruction, 
residues 109-133 were divided into three blocks based on sequence conservation (Fig. 4.2A) 
and alanine mutagenesis was used to assess the importance of each group of residues in the 
timing of securin degradation (Fig. 4.2B). The first mutant, securin DAYPEIE-A, initially 
predicted to eliminate prometaphase targeting due to its similarity to the PM motif in cyclin 
B1 was instead targeted in time with securin FL, whereas securin FFPFNP-A and DFESFD-A 
where both degraded at a later time (Fig. 4.2C). Securin FFPFNP-A was targeted for 
destruction approximately 60 minutes after securin FL but still ~20 minutes ahead of securin 
N101 (Fig. 4.2D), whereas securin DFESFD-A was targeted in time with securin N101 (Fig. 
4.2E). This suggests that essential residues for wild-type prometaphase securin degradation lie 
within both regions. The interaction which mediates this early degradation is likely 
strengthened by residues within FFPFNP. However, DFESFD-A gave the most striking 
phenotype and opened up the possibility of identifying discrete residues critical for 
prometaphase destruction. 
Further point mutations within DFESFD highlighted a pair of conserved phenylalanine 
residues, F125 and F128, which when substituted for alanines (securin FxxF-A) delayed 
degradation by ~90 minutes in time with securin N101 (Fig. 4.2F). These two phenylalanine 
residues appear to constitute crucial residues of a novel interacting region (hereafter named 
the FxxF motif) able to direct APC/C-mediated proteolysis of securin in late prometaphase I 
in mouse oocytes. Destruction timings for all securin truncations and mutations are 
summarised in figure 4.3. 
To confirm that the differences observed in degradation timing between securin FL and 
securin FxxF-A was not simply due to differences between protein expression of the two 
different mRNA constructs, oocytes were treated with cycloheximide (CHX) to block protein 
synthesis (Fig. 4.2G). On addition of CHX, securin FL was evident (~10% of the total protein 
was lost). The rate of degradation then increased ~3.5 hours after CHX addition. Securin  
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Figure 4.2. A second destruction motif exists within the C-terminus of securin. (A) 
Alignment of residues 109-133 in securin orthologs. (B) Securin residues 109-133 sequence 
detail showing the nomenclature of Venus-tagged securin mutations. (C) Average securin 
FL::VFP (orange, n=25), securin N101::VFP (blue, n=23) and securin DAYPEIE-A::VFP 
(light blue, n=19) destruction traces aligned at PB1 extrusion. (D) Average securin FL::VFP 
(orange, n=25), securin N101::VFP (blue, n=23) and securin FFPFNP-A (purple, n=23) 
destruction traces aligned at PB1 extrusion. (E) Average securin FL::VFP (orange, n=25), 
securin N101::VFP (blue, n=23) and securin DFESFD-A (red, n=20) destruction traces 
aligned at PB1 extrusion. (F) Average securin FL::VFP (orange, n=25), securin N101::VFP 
(blue, n=23) and securin FxxF-A (green, n=20) destruction traces aligned at PB1 extrusion. 
(G) Average securin FL::VFP (orange, n=24) and securin FxxF-A (green, n=27) on addition 
of cycloheximide to inhibit protein synthesis. Traces are aligned to the addition of cyclohex-
imide at 3 hours post GVBD. Error bars = +/- SEM.
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Figure 4.3. Securin constructs destruction timings. (A) Destruction of Venus-tagged securin 
truncations and mutants. Schematic representations of securin constructs are shown down the right 
hand side, while the bars to the left indicate destruction timings. The length of each bar indicates the 
number of minutes ahead of the minimum fluorescence/maximum destruction point (time 0). The 
open, white bars indicate the point at which 75% of the destruction has taken place. The light red 
extension to this bar indicates the point at which 50% of the destruction has taken place (error bars = 
SEM), followed by a dark red extension indicating the point at which 25% of the destruction has 
taken place. The period over which PB1 extrusions occur is shaded in grey.  
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FxxF-A protein appears to be turned over far less readily, instead remaining mostly stable 
until it was targeted for degradation ~5 hours after CHX addition. Critically, the securin 
FxxF-A becomes a target ~90 minutes after securin FL, consistent with results from non 
CHX-treated oocytes. 
 
4.2.3 The FxxF motif is likely to be masked when securin is bound to separase. 
The recently solved structure of the S. cerevisiae separase-securin complex (Luo & Tong 
2017) has allowed us to see that residues Y276 and F279 which correspond to F125 and F128 
in the human protein sit deep within a hydrophobic binding pocket on the surface of separase 
(Fig. 4.4A), making it likely that these two residues are obscured when securin is in complex 
with separase, yet visible when securin is free. This provides a mechanism by which an 
unbound pool of securin could be targeted preferentially in late prometaphase ahead of 
separase-bound securin, preventing premature separase activation.  
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Figure 4.4. The FxxF motif is likely to be masked when securin is in complex with sepa-
rase. (A) Molecular surface of the separase interaction segment of securin (purple) bound to 
separase (green) from the crystal structure of the Saccharomyces cerevisiae separase-securin 
complex (Luo & Tong, 2017.). The side chains of securin residues Y276 and F276, which 
correspond to F125 and F128 in the human protein, are shown as stick models. (B) Alignment 
of FxxF motif-containing region in securin orthologs.
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4.3 Discussion 
Securin destruction in mitosis begins at metaphase, once the spindle checkpoint is satisfied 
and mirrors that of cyclin B1. Degradation of both proteins is required before sister 
chromatids can properly separate (Hagting et al. 2002). In mouse oocytes, securin has also 
been shown to be targeted for destruction in time with cyclin B1 (Homer et al. 2005). Beyond 
this however, there is very little meiosis specific securin data with the majority of studies 
carried out in mitosis. Since we know that cyclin B1 is regulated in a different way in meiosis 
(chapter 3), given that securin and cyclin B1 are destroyed synchronously, it became 
important to explore the possibility of a similar biphasic destruction mechanism for securin in 
meiosis I mouse oocytes. 
To address this question, mouse oocytes were microinjected with cRNA encoding full-length 
securin alongside an N-terminal truncation containing only the D-box and neighbouring 
lysine residues yet critically missing highly conserved regions within the C-terminus of the 
protein. It was found that the destruction of full-length securin mirrors that of full-length 
cyclin B1 in oocytes as previously observed by Homer et al. 2005, initiating at a time point 
when checkpoint proteins are still observed at the kinetochore (Kitajima et al. 2011; Lane et 
al. 2012) and the spindle is yet to migrate to the cortex (Verlhac et al. 2000). A D-box only N-
terminal truncation is targeted approximately 80 minutes later than full-length securin and 
critically in time with a cyclin B1 mutant lacking its PM motif. Given that an additional motif 
was necessary to permit late prometaphase destruction of cyclin B1 (Chapter 3; Levasseur et 
al. 2017 unpublished), this made it likely an additional sequence may exist in the C-terminus 
of securin; a motif able to cooperate with the D-box and direct APC/C-mediated degradation 
in prometaphase I oocytes prior to full checkpoint satisfaction. 
To investigate this and narrow down the region within the C-terminus of securin mediating 
prometaphase destruction, a number of extensions based on sequence conservation were made 
to the initial N-terminal truncation. This revealed that a region within residues 109-133 is 
essential for prometaphase degradation of securin in meiosis (Fig. 4D-E).  
Based on sequence similarity to the PM motif of cyclin B1 (DIYxxLRQL), it was predicted 
that the region surrounding securin residues 109DAY111 was a likely candidate, mediating late 
prometaphase degradation in oocytes. A theory strengthened by a report that in humans, 
primates and rodents, securin residues 108-113 (DDAYPE) form an unconventional βTrCP 
recognition motif that targets securin for SCFβTrCP-mediated degradation, principally 
following UV-irradiation damage, but also involved in securin turnover in normal cells 
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(Limón-Mortés et al. 2008). Surprisingly however, an alanine mutation that eliminated 
residues 109-115 was still degraded during prometaphase and mirrored the destruction profile 
of full-length securin (4.2B-C).  
Further mutations within residues 109-133 highlighted a pair of conserved phenylalanine 
residues, F125 and F128, which when substituted for alanines in an otherwise wild-type 
securin delayed degradation by ~80 minutes in time with the D-box only N-terminal 
truncation (Fig. 4.2F) and critically the cyclin B1 PM mutant. I suggest that these two 
phenylalanine residues constitute crucial residues of a novel interacting region (hereafter 
named the FxxF motif) able to direct APC/C-mediated proteolysis of securin in late 
prometaphase I in mouse oocytes. While the presence of F125 and F128 are clearly essential 
for wild-type destruction, I also acknowledge that neighbouring residues and regions also play 
an important role, namely residues within 117FFPFNP122 and the region spanning residues 
133-159. Interestingly, whilst degradation timings of the securin FxxF mutant and the cyclin 
B1 PM mutant appear to mirror each other, much like the wild-type proteins, the motifs 
themselves have very little in common. 
The recently solved structure of the S. cerevisiae separase-securin complex (Luo & Tong 
2017) has allowed us to visualise how the FxxF motif might be positioned when securin is in 
complex with separase as yeast separase shares the same elongated same as human separase. 
Residues Y276 and F279 which correspond to F125 and F128 in the human protein sit deep 
within a hydrophobic binding pocket on the surface of separase (Fig. 4.4A), making it likely 
that these two residues are obscured when securin is in complex with separase, yet visible 
when securin is free. This provides a mechanism by which an unbound pool of securin could 
be targeted preferentially in late prometaphase ahead of separase-bound securin, preventing 
premature separase activation. Important to note is that whilst the primary amino acid 
sequence of securin is generally poorly conserved through evolution, the D-box and region 
surrounding the FxxF motif are well conserved down to yeast (see Appendix for full 
alignment of securin orthologs). 
Initial quantification blots suggest that securin is in large excess over separase in oocytes. 
Securin is known to be in excess in mitotic cells (Hellmuth et al. 2014). In MEFs, U2OS and 
HeLa, we are able to detect both separase and securin bands via immunoblot. However in 
mouse oocytes, while we are readily able to detect securin, we have not been able to detect 
separase (investigations are on going) despite neighbouring wells giving strong separase band 
for mitotic cells (MEFs, U2OS and HeLa). This suggests that in meiosis, securin is in huge 
excess of separase. An excess of free-securin may be targeted preferentially during late 
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prometaphase via its visible FxxF motif, potentially as a buffer zone, allowing the oocyte time 
to manage its highly complex spindle assembly without affecting separase inhibition 
prematurely. This theory will be discussed in further detail in chapter 7. 
The idea of preferential targeting of free securin is not without president. In HeLa cells, 
separase-bound securin is dephosphorylated by PP2A-B56 phosphatase, whereas free securin 
exists in a phosphorylated state and is thus a preferential APC/C target, though this 
destruction takes place only after checkpoint satisfaction (Hellmuth et al. 2014). 
It has been suggested that securin is present in excess of separase in mitosis, with free securin 
present at 4-5x the abundance of separase-bound securin in HeLa cells (Hellmuth et al. 2014). 
Why then is free securin destruction not seen in mitosis, prior to checkpoint satisfaction? It is 
important to note that HeLa cells are an immortalised cancer cell line and likely do not reflect 
the securin to separase ratio in healthy somatic cells. This may explain why the FxxF motif 
does not appear to target securin for prometaphase destruction in mitosis, however it may still 
have a role in housekeeping should securin become overexpressed. Another possibility is that 
some degree of prometaphase securin destruction does take place in mitosis yet is 
undetectable due to the relative speed of the metaphase anaphase transition in comparison to 
meiosis. Other studies have also noted securin to be in excess of separase though here without 
rigorous quantification (Ciosk et al. 1998; Shindo et al. 2012; Kamenz et al. 2015). 
Possible mechanisms for the prometaphase destruction of securin in meiosis will be discussed 
in chapters 5 and 6. Clues to solving this can be taken from known prometaphase APC/C 
substrates such as cyclin A, Nek2A and HOXC10 which are degraded rapidly in 
prometaphase as soon as the nuclear envelope breaks down (NEBD) (Elzen & Pines 2001; 
Geley et al. 2001; Gabellini et al. 2003; Hayes et al. 2006). The mechanism by which the 
FxxF motif mediates prometaphase securin destruction in oocytes, as well as the role of this 
novel mechanism in protecting separase inhibition, will be addressed in chapter 5. 
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Chapter 5: The FxxF motif in securin functions alongside a D-box 
to promote preferential degradation of free securin ahead of 
separase activation in meiosis I mouse oocytes. 
 
5.1 Introduction 
In chapter 4, the existence and location of a novel and conserved FxxF motif within the C-
terminus of securin was uncovered. The FxxF motif permits destruction in late prometaphase, 
two hours ahead of a securin mutant construct lacking this motif. This destruction takes place 
at a time when weak Mad2 staining is still detectable at kinetochores (Lane & Jones 2014) 
and the meiotic spindle is yet to fully migrate to the cortex (Verlhac et al. 2000; Kitajima et 
al. 2011). In this chapter I will begin to discuss how this motif promotes destruction during a 
period of active checkpoint signalling and further aim to explore the roles of other known 
destruction motifs, namely the KEN box and D-box, in meiotic securin destruction. In 
addition to understanding the mechanism by which securin seems able to bypass an active 
checkpoint, the aim was to investigate the relationship between this prometaphase destruction 
and meiotic separase activity. Precocious separase activity would likely have disastrous 
consequences, therefore the early loss of securin seems at odds with the requirement of the 
oocyte. 
In mitosis, the majority of securin destruction is mediated by the large multi-subunit E3 
ubiquitin ligase the anaphase promoting complex or cyclosome (APC/C) (Hagting et al. 
2002). However further studies have also highlighted a number of additional E3 ligases at 
least partially responsible for securin destruction in a number of different situations and cell 
types. The SCFβTrCP has been shown to mediate destruction when securin becomes 
abnormally hyper-phosphorylated through inhibition of the phosphatase PP2A, a situation that 
may arise in certain cancers (Gil-Bernabé et al. 2006). The same group also showed that UV 
irradiation had a similar effect, SCF-mediated securin degradation was triggered following a 
standard exposure to UV (100 J/m2). Here a discrete motif within the C-terminus of securin 
(DDAYPE) was identified as being responsible for mediating the interaction with the SCF. In 
the same study, the SCF was also shown to have a role in securin turnover in healthy cells 
(Limón-Mortés et al. 2008). More recently, Parkin, an E3 ubiquitin ligase involved in 
Parkinson’s disease has been observed to interact with Cdc20 and Cdh1, targeting securin and 
a number of other substrates including cyclin B1 and Nek2A for mitotic degradation 
47
alongside the APC/C (Lee et al. 2015). In mouse embryonic fibroblasts (MEFs), Smurf1 
directly interacts with securin and targets it for proteasomal degradation. When Smurf1 is 
knocked down, sister chromatid segregation is strongly inhibited and marked delay in 
anaphase onset is observed (Wei et al. 2017), likely due to an extended period of separase 
inhibition.  
While there is far less known about securin degradation in meiosis, one study has suggested 
securin degradation in mouse oocytes to be entirely APC/C-dependent, due to securin 
stabilisation when the D-box is mutated (Herbert et al. 2003). However, since a new motif has 
been identified within securin, it becomes critical revisit this theory and investigate how the 
D-box, KEN box and FxxF motif are working together to mediate meiotic degradation. 
The APC/C is able to recognise its substrates through two co-activators, Cdc20 and Cdh1, 
each of which contain WD40 domains serving as major sites for substrate recognition (Kraft 
et al. 2005; Chao et al. 2012). Through domains within the APC/C subunits and its co-
activators, the APC/C is able to recognise a range of short motifs, known as degrons (Davey 
& Morgan 2016). Aside from the two well-characterised APC/C degrons (the D-box and KEN 
box), there exists also the newly discovered ABBA motif, originally identified in cyclin A and 
consisting of the consensus motif Fx[ILV][FHYx[DE]. The ABBA motif has been shown to 
outcompete a similar motif within BubR1 for an ABBA-binding domain in Cdc20 thus 
permitting APC/C activation during an active checkpoint (Di Fiore et al. 2015).  
As well as the newly discovered FxxF motif (chapter 4), and in addition to the D-box, human 
securin contains a further classic APC/C degron, namely a KEN box. In mitosis, securin 
degradation begins in metaphase once the spindle checkpoint is satisfied and is mediated 
primarily by APC/C-Cdc20. This degradation requires only the D-box and not the KEN box 
(Hagting et al. 2002). However when key D-box residues are replaced via alanine 
mutagenesis, the KEN box takes over and degradation is pushed back to a later time point, 
following anaphase (Hagting et al. 2002). This KEN box only mediated degradation likely 
indicates a time in mitosis when APC/C-Cdh1 activity replaces that of APC/C-Cdc20. If both 
the KEN box and D-box are mutated in tandem, securin is largely stabilised in mitotic cells 
(Hagting et al. 2002). While not strictly degrons, human securin also contains two TEK 
boxes, mutation of which impairs initiation of ubiquitin chain formation by E2 ubiquitin 
conjugating enzyme, Ube2C (Jin et al. 2008). 
Securin destruction in mouse oocytes begins 3 hours ahead of polar body extrusion (Chapter 
4) at a time when weak Mad2 staining is still detectable at kinetochores, suggesting that a 
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reduced yet active checkpoint is still signalling (Lane et al. 2012). In mitosis, while 
chromosomes are still correctly aligning on the spindle, APC/C activation is strongly 
inhibited by the spindle checkpoint, a diffusible “wait anaphase” signal propagated from 
unattached kinetochores (Musacchio & Salmon 2007). The spindle checkpoint signal is 
generated primarily through the action of Mad2 and BubR1 (Sczaniecka et al. 2008), which 
act to sequester Cdc20 in a number of ways. As part of the mitotic checkpoint complex 
(MCC), Mad2 prevents association of free Cdc20 with the APC/C by outcompeting APC8 for 
binding of the KILR motif in Cdc20 (Izawa & Pines 2014). The MCC can then bind a second 
APC/C-bound Cdc20 through a conserved ABBA-KEN-ABBA binding cassette, preventing 
Cdc20 from interacting with APC3 (whilst still bound to APC8) and hence removing the 
bipartite D-box receptor formed with APC10 (Izawa & Pines 2014; Di Fiore et al. 2016). 
Cdc20 therefore shows a shift in the way it interacts with the APC/C depending on whether 
the checkpoint is on or off. When the checkpoint is on Cdc20 interacts with APC8 only, 
whilst when the checkpoint is satisfied and MCC production ceases, Cdc20 is free to also 
interact with APC3 and form a D-box receptor with the neighbouring APC10, thus initiating 
cyclin B1 and securin degradation (Izawa & Pines 2011). While chromosomes are still 
aligning during prometaphase both APC/C co-activators are suppressed. The spindle 
checkpoint acts to inhibit Cdc20, and Cdh1 is inhibited through Cyclin B1-Cdk1 
phosphorylation (Zachariae 1998).  
In contrast to mitotic cells where MCC complexes formed in the cytoplasm are sufficient for 
correct prometaphase timing (Maciejowski et al. 2010), mouse oocytes also require 
kinetochore localisation of MPS1 (whose role is discussed in Chapter 1) for correct timing of 
prometaphase I (Hached et al. 2011). This supports a long held theory that diffusible MCC 
complexes are insufficient over a large volume (Minshull et al. 1994), as is the case in a 
mouse oocyte. This is further evident in a recent study in C. elegans embryonic cells, where 
the strength of checkpoint was directly related to the ratio of kinetochores to cytoplasmic 
volume ratio (Galli & Morgan 2016). 
Unlike in mitosis, where a single unattached kinetochore is sufficient to induce cell cycle 
arrest (Rieder et al. 1994), it has previously been suggested that APC/C activation in mouse 
oocytes can take place in the presence of multiple incorrect attachments since cyclin B1 and 
securin are destroyed so early (Gui & Homer 2012; Lane et al. 2012). Late prometaphase 
destruction of cyclin B1 and securin has therefore previously been considered as evidence of 
this inefficient or diluted checkpoint, resulting in a precocious degradation of APC/C 
metaphase substrates. However, previous chapters have shown that D-box only mediated 
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degradation is still insufficient for wild-type prometaphase destruction and that additional 
discrete motifs within the two proteins are also required.  
In mitosis, there is a delay observed between the initiation of securin degradation and the 
activation of separase. In some systems, this delay is at least in part due to the 
phosphorylation state of securin. In human cells, phosphorylated free securin is targeted 
preferentially over separase-bound securin due to dephosphorylation by PP2A in complex 
with separase, thus delaying separase activation (Hellmuth et al. 2014). In budding yeast, the 
situation is reversed and Cdk1-dependent phosphorylation of securin has in fact been shown 
to delay degradation (Lu et al. 2014).  
Securin destruction is observed for 3 hours ahead of polar body extrusion in meiosis I mouse 
oocytes. In chapter 4 it was hypothesised that preferential degradation of free securin via its 
FxxF motif may function to protect against premature separase activation, since a later second 
wave of securin destruction relying only on its D-box does not begin until 90 minutes prior to 
PB1 extrusion. However, initiation of separase activation even 90 minutes ahead of PB1 
extrusion would still likely be catastrophic due to cohesin cleavage so far ahead of anaphase. 
It is therefore, alongside the role of the KEN box and D-box, a primary point of interest to 
investigate the exact timing and regulation of separase activity in oocytes.  
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5.2 Results 
5.2.1 Meiotic securin destruction is D-box-dependent but not KEN box-
dependent. 
Following identification of a discrete FxxF motif within the C-terminus of securin (chapter 4) 
I wanted to investigate how this functioned alongside the D-box and KEN box to mediate 
meiotic destruction.  Alignment of metazoan securin orthologs showed that while the 
consensus D-box motif is well conserved throughout; the canonical KEN box is lost even in 
mouse, where it is replaced by KDN. The mouse KDN sequence in securin would be unlikely 
to be recognised as a functional KEN motif since if the Cdc20 KEN box is mutated to KDN 
in mouse cell lines, Cdc20 is stabilised (Zur & Brandeis 2002) (Fig. 5.1A). This suggests that 
while the KEN box has been shown to be functional in humans when the D-box is mutated 
(Hagting et al. 2002), its functional significance seems of far less evolutionary importance 
than the D-box.  
To assess the functionality of securin degrons in meiosis, three mutant securin constructs were 
tested, a KEN box mutant in which all three core residues were replaced with alanines 
(KEN>AAA, securin KEN mutant), a D-box mutant in which the three key residues forming 
the consensus motif, the arginine in position 1, the leucine in position 4 and the asparagine in 
position 8 were replaced with alanines (RKALGTVN>AKAAGTVA, securin D-box mutant) 
and finally a double mutant that combined both degron mutations (securin KEN/D-box 
mutant). Securin KEN mutant was targeted with an identical destruction profile to that of a 
wild-type securin construct (securin FL; Fig. 5.1B), while mutation of the D-box inhibited FL 
securin destruction (Fig. 5.1C-D). Though largely stabilised, in contrast to a previous study 
that found D-box mutation to completely stabilise securin in mouse oocytes, evidence of 
destruction was still observed in the fluorescence profiles of individual oocytes injected with 
securin D-box mutant, however this effect is lost in the average trace. Degradation here never 
exceeds 25% and is completely lost in the securin KEN/D-box mutant, which is completely 
stable (Fig. 5.1D). This suggests that while meiotic securin degradation is largely D-box 
dependent, when the D-box is mutated a small amount of destruction can be maintained via 
the KEN box. However, unlike in mitotic studies there does not appear to be a significant 
change in the timing of KEN-box mediated degradation, indeed some destruction profiles for 
securin D-box mutant constructs show targeting even ahead of securin FL (Fig. 5.1C). 
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Figure 5.1. Meiotic securin destruction is D-box dependent but not KEN box dependent. 
(A) Alignment of residues 1-69 in securin orthologs containing both KEN box and D-box 
motifs. (B) Average securin FL::VFP (orange, n=25) and securin KEN mutant::VFP (purple, 
n=20) destruction profiles aligned at PB1 extrusion. (C) Average securin FL::VFP (orange, 
n=16) and securin D-box mutant::VFP (light blue, n=23) destruction profiles aligned at 
GVBD. (D) Average securin FL::VFP (orange, n=16) and securin KEN/D-box mutant::VFP 
(red, n=19) destruction profiles aligned at GVBD. Both securin D-box mutant and securin 
KEN/D-box mutant were largely stabilized and blocked anaphase progression, therefore 
destruction profiles are aligned at GVBD rather than PB1 extrusion. Fine traces represent 
destruction profiles from individual oocytes, heavy traces represent the average destruction 
profile resulting from all injected oocytes of a given contruct.
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5.2.2 The FxxF motif in securin functions to bypass an active checkpoint in 
late prometaphase I oocytes and is involved in preferential targeting of free 
securin once the spindle checkpoint is satisfied. 
Securin destruction in mouse oocytes begins in late prometaphase at a time when Mad2 
staining is still detectable at kinetochores (Lane et al. 2012), however it is not known exactly 
how much control the spindle checkpoint has over FxxF-driven degradation. To investigate 
this, oocytes were treated with 150 nM nocodazole to depolymerise microtubules. This 
activates the checkpoint such that PB1 extrusion is blocked in >95% of oocytes. It was 
observed that while the rate of full-length securin degradation was dramatically reduced, it 
was still almost fully degraded by 20 hours, whereas securin FxxF-A was almost completely 
stabilised (Fig. 5.2A).  This suggests that the destruction of securin in late prometaphase I is 
not simply due to a checkpoint signal that is insufficient over the large volume of an oocyte, 
but that the FxxF motif is actively involved in bypassing a checkpoint signal that can still 
sufficiently block D-box only APC/C substrates. 
To further investigate the role of the FxxF motif in securin degradation, oocytes were treated 
with 100nM reversine to inhibit MPS1 and block the assembly of new MCC complexes. As 
expected, reversine treatment rapidly accelerated the meiotic cell cycle, with securin 
degradation beginning ~30 minutes after drug addition (Fig 5.2B). In reversine-treated 
oocytes, securin FL was still consistently targeted for destruction ~60 minutes ahead of 
securin FxxF-A (Fig 5.2B). This demonstrates that whilst the FxxF motif is necessary to 
bypass an active checkpoint, even once the spindle checkpoint is inactivated, FL securin (in 
which the FxxF motif is visible) is still the preferential APC/C substrate ahead of separase-
bound securin in which only the D-box is visible. 
 
5.2.3 APC3 and Cdc20 levels are rate limiting for prometaphase securin 
destruction. 
Wild-type meiotic securin destruction begins in late prometaphase and is mediated via the 
FxxF motif which functions to bypass an active spindle checkpoint (Fig 5.2A). However, the 
FxxF motif must function alongside the D-box, given D-box mutation largely stabilises 
securin destruction (Fig 5.1C). The requirement for a D-box would suggest APC/C-Cdc20 
activity is responsible for early securin degradation, as the D-box is recognised by a bipartite 
receptor formed between the WD40 domain of Cdc20 and APC/C subunit APC10 (Chao et al.  
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Figure 5.2. The FxxF motif in securin functions to bypass an active checkpoint and is involved 
in preferential targeting of free securin once the SAC is satisfied. (A) Average securin FL::VFP 
(orange, n=20) and securin FxxF-A (green, n=30) destruction profiles on addition of nocodazole to 
arrest oocytes in prometaphase. Traces are aligned to GVBD as oocytes did not extrude polar bodies. 
(B) Average securin FL::VFP (orange, n=21) and securin FxxF-A (green, n=18) on addition of 
reversine to inhibit MCC formation. Traces are aligned to reversine addition, however a second x-axis 
above the graph shows timing relative to average GVBD. Fine traces represent destruction profiles 
from individual oocytes, heavy traces represent the average destruction profile resulting from all 
injected oocytes for a given construct.
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2012). To test this, a pool of oocytes was injected with an APC3 morpholino oligomer (MO), 
to knock down APC3 gene expression and thus inhibit APC/C activity (Nilsson et al. 2009), 
followed by a separate injection of securin FL. In these oocytes, securin degradation was 
drastically reduced in comparison with control securin FL oocytes (Fig. 5.3A). In a similar 
experiment Cdc20 levels were knocked down and gave a surprising result. Securin FxxF-A 
was completely stabilised, yet while the rate of securin FL destruction was reduced, destroyed 
over a 5 hour time period rather than 3 hours, it was still fully degraded (Fig. 5.3B). This 
suggests that early securin targeting is permitted at much lower concentrations of Cdc20, 
perhaps due to the high affinity of combining an FxxF motif with a D-box. In comparison, 
late D-box only degradation requires much higher levels of Cdc20 for APC/C targeting.  
Interestingly, when Cdc20 is knocked down by MO injection, securin FL is targeted for 
degradation ~2 hours ahead of securin FL in control oocytes (Fig 5.3B), yet polar body 
extrusion is blocked. This could be due to upregulation of Cdh1 in Cdc20 MO-injected 
oocytes, a situation in which the spindle checkpoint may be less able to prevent premature 
APC/C activation. However, this requires further investigation. 
 
5.2.4 Meiotic securin destruction begins 2.5 hours ahead of separase 
activation in meiosis I mouse oocytes. 
I hypothesise that early meiotic securin degradation represents destruction of a free pool of 
securin, targeted preferentially via a FxxF motif that is obscured when securin is bound to 
separase, thus preventing premature activation of separase while chromosomes are correctly 
aligning.  Following this initial phase of destruction a second wave of securin destruction 
initiates 90 minutes ahead of PB1 extrusion. Here the D-box alone is sufficient to target 
securin for degradation, however the gradual activation of separase this far ahead of anaphase 
would be potentially catastrophic for faithful chromosome segregation. Separase activation 
from this early time point would lead to cohesin cleavage and homolog dissociation before the 
cell was ready to proceed into anaphase. We therefore reasoned that separase activity must 
still be delayed even after the 2nd wave of securin destruction is initiated.  
To address this, the H2B-mCherry-Scc1147-467-eGFP separase activity biosensor was used 
(Nam & van Deursen 2014) (Fig. 5.4C). The sensor is targeted to chromosomes via its histone 
H2B tag and shows a colour shift from yellow to red as separase becomes active and cleaves 
two cut sites within the Scc1 peptide, causing eGFP dissociation into the cytoplasm leaving 
only mCherry signal on the DNA. Separase activation was typically observed 20-30 minutes  
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Figure 5.3. APC3 and Cdc20 levels are rate limiting for meiotic securin destruction. (A) 
Average securin FL::VFP (orange, n=16) and securin FL + APC3 morpholino oligomer (MO) 
(purple, n=15) destruction profiles aligned at GVBD. (B) Average securin FL + Cdc20 MO::VFP 
(orange, n=19), securin FxxF-A + Cdc20 MO (green, n=19) and control securin FL::VFP (orange 
dashed, n=16) destruction profiles aligned at GVBD. Traces were aligned at GVBD as both APC3 
and Cdc20 MOs prevented polar body extrusion. Fine traces represent destruction profiles from 
individual oocytes, heavy traces represent the average destruction profile resulting from all injected 
oocytes for a given construct.
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B.
Figure 5.4. Prometaphase securin degradation begins 2.5 hours ahead of separase 
activation. (A) Time-lapse images of oocyte injected with a H2B-mCherry-Scc1-eGFP 
separase activity biosensor and imaged at 10 minute time intervals starting 5 hours after 
GVBD. Representative fluorescence (eGFP in green and mCherry in red) and bright field 
images are shown during the 50 minutes surrounding PB1 extrusion. Scale bars = 50µm. (B) 
Quantification of separase activity by measuring the average eGFP/mCherry fluorescence 
ratio from eggs injected with the separase biosensor (green, n= 20), plotted alongside aver-
age securin FL::VFP (orange, n=25) and securin FxxF-A::VFP (blue, n=20) destruction 
profiles produced by taking an average intensity reading from a defined region of interest 
around the oocyte, plotted over time and aligned at PB1 extrusion. Error bars = +/- SEM. 
(C) Schematic representation of separase activity biosensor adapted from Shindo et al. 2012.
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ahead of polar body extrusion as can be seen in a representative oocyte (Fig 5.4A). This 
timing was confirmed by quantification of the eGFP/mCherry fluorescence ratio which 
showed that separase became active ~30 minutes ahead of polar body extrusion, 60 minutes 
after D-box only mediated destruction commences, with the majority of substrate cleavage 
taking place in the final 20 minutes Fig. 5.4B). 
 
5.2.5 A securin phosphomutant does not significantly affect degradation 
timing in meiosis I mouse oocytes. 
Given that 90 minutes prior to anaphase the D-box alone becomes sufficient to target securin 
for degradation, yet separase remains inactive for an hour subsequent to this suggests an 
additional layer of separase regulation once checkpoint signalling ceases. In mitosis, a pool of 
phosphorylated free securin is targeted for destruction preferentially ahead of a separase-
bound securin pool protected by PP2A-mediated dephosphorylation (Hellmuth et al. 2014). I 
wanted to investigate whether similarly in oocytes the phosphorylation state of securin affects 
its degradation timing. To address this, 4 residues highlighted to be important for 
phosphorylation-dependent timing of mitotic securin degradation were replaced with alanines 
in both a wild-type and FxxF-A securin. Surprisingly neither phosphomutant, securin FL 4A 
or securin FxxF-A 4A showed a delayed degradation when compared to securin FL and FxxF-
A respectively (Fig. 5.5A-B). Interestingly however, securin FxxF-A 4A was in fact targeted 
~30 minutes ahead of securin FxxF-A, suggesting that phosphorylation may actually delay 
degradation in oocytes (as is the case in budding yeast (Lu et al. 2014)), however this would 
require further investigation to fully characterise (Fig. 5.5B). 
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Figure 5.5. A securin phosphomutant does not significantly affect degradation timing in 
meiosis I mouse oocytes. (A) Average securin WT 4A::VFP (blue, n=17) and securin FxxF-A 
4A::VFP (red, n=20) destruction profiles aligned at PB1 extrusion. Fine traces represent destruc-
tion profiles from individual oocytes, heavy traces represent the average destruction profile 
resulting from all injected oocytes for a given construct. (B) Average securin WT 4A::VFP (blue, 
n=17), securin FxxF-A 4A::VFP (red, n=20), securin WT::VFP (orange dashed, n=25) and securin 
FxxF::VFP (green dashed, n=20) destruction profiles aligned at PB1 extrusion. Error bars = +/- 
SEM.
A.
B.
Securin WT 4A 
Securin FxxF-A 4A 
-5 -4 -3 -2 -1 0 1 2 
Time in hours relative to PB1 
20 
40 
60 
80 
100 
120 
Re
la
ti
ve
 s
ec
ur
in
 
uo
re
sc
en
ce
 (A
.U
.)
0 
Securin WT  
Securin FxxF-A 
Securin WT 4A 
Securin FxxF-A 4A 
64
5.3 Discussion 
Meiotic securin destruction in mouse oocytes is biphasic; consisting of an initial phase during 
late prometaphase in which free securin is targeted preferentially via a FxxF motif ahead of 
separase-bound securin in which the FxxF motif is masked in the interface between securin 
and separase (chapter 4). This is followed by a second phase of destruction initiating 90 
minutes ahead of polar body extrusion where the D-box alone is sufficient.  
In APC3 knockdown oocytes, securin degradation was drastically reduced in line with the 
APC/C being the primary E3 ubiquitin ligase mediating meiotic degradation (Fig. 5.3A). To 
investigate how securin’s known APC/C degrons, namely the KEN box and D-box, function 
alongside the FxxF motif to mediate prometaphase I destruction, securin constructs were 
tested with either KEN box or D-box mutations or both combined. It was observed that 
contrary to a previous report (Herbert et al. 2003), when only the D-box is mutated, the KEN 
box is able to direct minimal degradation. This is not observed in the double KEN/D-box 
mutant (Fig. 5.1C-D). Unlike in mitotic cells, there was no time delay associated with this 
switch from D-box to KEN box mediated destruction (Hagting et al. 2002). This could 
suggest that Cdh1 may not be as strongly inhibited prior to anaphase as it is in mitotic cells 
where a D-box mutant securin is only targeted for degradation following anaphase once 
Cdk1-mediated Cdh1 inhibition ceases and the APC/C switches co-activators from Cdc20 to 
Cdh1 (Hagting et al. 2002). Indeed APC/C-Cdh1 has been shown to moderate the rate of 
Cdk1 activation prior to GVBD in mouse oocytes, suggesting that especially in early 
prometaphase, there may be more Cdh1 available to activate the APC/C when compared to 
that in mitotic cells (Reis et al. 2007; Rattani et al. 2017). Despite this, securin destruction in 
mouse oocytes was observed to be largely D-box dependent, as a KEN box mutation had no 
significant effect on destruction profile (Fig. 5.1D). This suggests that securin degradation 
during late prometaphase in mouse oocytes requires both D-box interaction with the bipartite 
receptor on APC-Cdc20 and the FxxF motif in order to bypass an active checkpoint and 
present itself as an APC/C substrate. Other examples of prometaphase APC/C substrates able 
to bypass an active checkpoint include Nek2A and cyclin A (Zon & Wolthuis 2010). While 
Nek2A targeting is Cdc20-independent and mediated via direct interaction with the APC/C, 
cyclin A must liberate Cdc20 from the MCC prior to APC/C activation (Hayes et al. 2006; Di 
Fiore & Pines 2010). Liberation of Cdc20 is achieved via an ABBA motif within the N-
terminus of cyclin A which outcompetes a similar motif in BubR1 for Cdc20 binding, thus 
freeing Cdc20 from the MCC and activating the APC/C during an active checkpoint. 
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Interestingly, the FxxF motif shows high sequence similarity to the ABBA motifs identified 
in cyclin A, BubR1 and Bub1. This will be further explored in chapter 6. 
Our hypothesis that the FxxF motif is involved in Cdc20 liberation from the MCC, allowing 
an APC10/Cdc20 D-box receptor to form during an active checkpoint is further strengthened 
by observations made in nocodazole-treated oocytes. When oocytes were incubated with 
nocodazole to depolymerise microtubules and stimulate the checkpoint, a wild-type securin 
construct was still fully degraded despite the fact that anaphase was blocked. In comparison a 
mutant construct lacking the FxxF motif was largely stabilised (Fig. 5.2A), evidence that the 
late prometaphase degradation of securin is not simply due to an inefficient checkpoint, but 
instead is a controlled mechanism. The FxxF motif functions to bypass an active checkpoint 
that would otherwise be sufficient to block D-box only mediated degradation since securin 
FxxF-A is stable in nocodazole treated oocytes.  
Morpholino oligo knockdown of Cdc20 reduced securin degradation, however not to the same 
extent as APC3 knockdown. In Cdc20 knockdown oocytes, wild-type securin was fully 
degraded yet with much slower degradation dynamics whilst securin FxxF-A mutant was 
mostly stabilised with only small amounts of degradation observed in certain eggs (Fig. 
5.3B). Early securin degradation relying on both the FxxF motif and the D-box is less 
sensitive to situations where Cdc20 levels are limited, suggesting that perhaps both degrons 
combined have a higher binding affinity. This leads to the hypothesis that requirement of both 
an FxxF motif and a D-box for late prometaphase securin destruction would suggest that the 
destruction machinery mediating this is APC/C-Cdc20, as it is between APC10 and the 
WD40 domain of Cdc20 that the bipartite D-box receptor is formed (Chao et al. 2012).  
The possibility cannot be ruled out that when Cdc20 is knocked down there is the potential for 
Cdh1 upregulation in order to substitute as primary APC/C co-activator during meiosis I, 
however further analysis including quantification of relative Cdc20 and Cdh1 levels following 
MO treatment is required and currently the only conclusion that can be drawn is that Cdc20 is 
indeed rate limiting for meiotic securin degradation. 
While meiotic securin destruction is initiated 3 hours ahead of the first polar body extrusion in 
mouse oocytes, using a separase biosensor I demonstrate that activation of separase is only 
observed 20-30 minutes before anaphase (Fig. 5.4A-C). Though it makes sense that separase 
would only become active over a short time period preceding polar body extrusion, the 
mechanisms that keep separase inhibited for a further hour after the D-box becomes a 
sufficient securin degradation signal remain a point of interest. In mitotic cells, securin 
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phosphorylation serves to protect against premature separase activation. Separase-bound 
securin is kept in a dephosphorylated state by PP2A and thus protected, while free securin is 
phosphorylated and thus preferentially targeted for degradation (Hellmuth et al. 2014). 
However, when these phosphorylation sites were mutated to alanines in a securin FxxF-A 
mutant, mimicking the dephosphorylated state of mitotic protected separase-bound securin, it 
was found that rather than being delayed, degradation instead began ~30 minutes ahead of 
securin FxxF-A (Fig 5.5A-B). This suggests that when securin is phosphorylated, degradation 
timing may in fact be delayed, a phenomenon previously observed in budding yeast (Lu et al. 
2014) but at odds with current mitotic data. 
Further clues as to how separase inhibition may be protected after checkpoint signalling 
reaches a minimum come from oocytes treated with reversine to remove MCC assembly. 
Even in oocytes lacking an active spindle checkpoint, wild-type securin was consistently 
targeted for degradation an hour ahead of securin FxxF-A, suggesting that even after 
checkpoint signalling has ceased, any excess free securin in which both the FxxF motif and 
D-box are visible will still be targeted preferentially, thus further delaying the point at which 
separase-bound securin becomes a target for APC/C-mediated degradation. However this 
potential mechanism for separase protection would only work if there was a sufficient excess 
of free securin remaining after the initial phase of destruction. Quantification of 
securin:separase ratio in oocytes is currently under investigation, with initial results 
suggesting a large excess of securin in oocytes matured for 6 hours post GVBD (data not 
shown). Following quantification, I intend to use the separase biosensor in securin MO-
injected oocytes to investigate how the timing of separase activation varies in a separase 
knockdown background. 
Preliminary imaging data shows securin to be localised throughout the cytoplasm yet absent 
from chromosomes prior to anaphase onset (data not shown). It is therefore of future interest 
whether securin-separase complex localisation could play a role in this delayed activation, in 
which separase relocalisation to chromosomes would be required following the removal of 
securin-mediated inhibition. To probe this idea, the separase biosensor could be targeted to 
the cell membrane to investigate whether separase activity is observed with different timing 
away from chromosomes.  
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Chapter 6: Cyclin A2 and APC/C processivity in meiosis I. 
 
6.1 Introduction 
In chapter 5 it was shown that late prometaphase securin destruction is mediated by both the 
FxxF motif and the D-box, which work together to permit degradation in the presence of an 
active checkpoint. Furthermore, it was shown that both APC/C activity and Cdc20 levels were 
rate limiting to this process. However is was not clear from these experiments how the FxxF 
motif works alongside the D-box to permit degradation when a D-box alone is insufficient. In 
this chapter, I will address the possibility that the FxxF motif could be behaving in a similar 
way to the ABBA motif of cyclin A, a theory based on a high degree of sequence similarity 
and the relative spatial positioning of the two degrons. I also discuss the potential 
functionality of a conserved PM motif within cyclin A2, given that a sequence within cyclin 
A shows homology to the prometaphase APC/C degron identified in cyclin B1 (presented in 
chapter 3). 
Through ubiquitin-mediated hydrolysis, the anaphase promoting complex or cyclosome 
(APC/C) targets specific substrates for proteolysis at specific times to drive ordered mitotic 
progression (Pines 2006). In mitosis, the multi-subunit APC/C has a number of prometaphase 
(Cyclin A, Nek2A and HOXC10), metaphase (Cyclin B and securin) and later substrates 
(Cdc20, Plk1 and the Aurora kinases) (see Pines 2006 for review). How the same ubiquitin 
ligase targets each specific substrate at a specific time is still not fully clear even in mitosis 
and involves a complex balance of a number of factors. These include phosphorylation, co-
activator abundance, subcellular localisation, relative substrate abundance, degrons and 
inhibitor binding (see Sivakumar & Gorbsky 2015 for review). 
The APC/C is largely inactive without one of its co-activators; Cdc20 and Cdh1. The 
presence and position of these co-activators is one of the best known decisive factors in 
influencing substrate specificity (Vodermaier 2001). Cdh1 is largely responsible for APC/C 
co-activation in early G1 phase and late M phase of the cell cycle (Pines 2006). However 
once the cell enters mitosis, cyclin B1-Cdk1 phosphorylation of APC/C subunits, APC3 and 
APC1, prevents Cdh1 binding and primes the APC/C for Cdc20 co-activation (Fujimitsu et al. 
2016). When in complex with Cdc20, the APC/C primarily targets substrates through 
formation of a putative bipartite destruction box (D-box) receptor between Cdc20 and APC10 
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(Chao et al. 2012), whereas APC-Cdh1 is able to target substrates with either a D-box or KEN 
box and does not require a phosphorylated APC/C (Kramer et al. 2000). 
In mitosis, the APC/C complexes with Cdc20 until a point when cyclin B1- Cdk1 activity 
falls and as a result the APC/C loses its priming phosphorylation for Cdc20 binding. At this 
point there is a switch back towards APC/C co-activation by Cdh1 and Cdc20 itself becomes 
a target for degradation (Pfleger & Kirschner 2000). Loss of Cdc20 from mitotic cells causes 
stabilisation of cyclin B1 and securin and results in metaphase arrest (Li et al. 2007; Wolthuis 
et al. 2008), Cdh1 depletion stabilises the Aurora kinases and causes premature S-phase entry 
(Floyd et al. 2008). While chromosomes are still aligning during prometaphase both APC/C 
co-activators are suppressed. The spindle checkpoint acts to inhibit Cdc20, and Cdh1 is 
inhibited by high cyclin B1-Cdk1 activity. Despite this, the APC/C is still active from very 
early on in mitosis. Cyclin A, Nek2a and HOXC10 are all degraded rapidly in prometaphase 
as soon as the nuclear envelope breaks down (NEBD) (Elzen & Pines 2001; Geley et al. 2001; 
Gabellini et al. 2003; Hayes et al. 2006). 
Cyclin A binds to Cdc20 during early mitosis and is targeted to the phosphorylated APC/C in 
early prometaphase as a Cdc20-Cyclin A2-Cdk2-Cks1 complex (Wolthuis et al. 2008), 
through the direct binding of Cks1 to phosphorylated APC3 subunits (Di Fiore & Pines 2010; 
Zon & Wolthuis 2010). Via its ABBA motif, cyclin A2 outcompetes BubR1 for a binding site 
on Cdc20, rendering cyclin A an APC/C target at a time when the spindle checkpoint is still 
actively sequestering both APC/C-bound and free Cdc20 (Di Fiore et al. 2016).  
While it is clear there is a role for Cks1 in this early degradation, it is not yet fully defined. In 
one report, when both Cks1 and Cks2 were knocked down using shRNA, cyclin A2 appeared 
to be stabilised by immunoblot (Wolthuis et al. 2008). However in another study, Di Fiore 
and Pines instead observe that when cyclin A2 is truncated to its first N-terminal 165 residues 
(a length lacking the cyclin folds involved in Cdk-binding and thus Cks1 association) it is still 
targeted for destruction, only this time 20 minutes after NEBD and WT cyclin A2 targeting, 
yet still 20-25 minutes ahead of anaphase onset (Di Fiore & Pines 2010). Wild-type 
destruction is then recovered when cyclin A2 N165 is artificially fused to Cks1 (Di Fiore & 
Pines 2010). 
Although depleting Cdc20 largely stabilises cyclin A2 (Di Fiore & Pines 2010), Nek2A 
degradation is unaffected (Boekhout & Wolthuis 2015). Nevertheless, though direct Cdc20 
binding is not required for Nek2A destruction, catalytic activation of the APC/C by Cdc20 at 
the beginning of the prophase to prometaphase transition is essential (Boekhout & Wolthuis 
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2015). Nek2A binds directly to TPR motifs in APC/C subunits through its C-terminal MR tail 
(Hames et al. 2001) and therefore does not require Cdc20 binding to be recruited to the 
APC/C. 
In this chapter the aim was to investigate how cyclin A is regulated in mouse meiosis I and in 
so doing provide insight to the mechanisms by which cyclin B1 and securin are able to evade 
the checkpoint in late prometaphase I.  
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6.2 Results 
6.2.1 The FxxF motif in securin resembles an ABBA motif in both positioning 
and sequence. 
The FxxF motif in securin and the PM motif in cyclin B1 both work alongside a D-box to 
permit APC/C-Cdc20 mediated destruction simultaneously in late prometaphase I (chapters 3 
and 4, Levasseur et al. 2017 unpublished). However, other than the seemingly identical 
temporal degradation profiles, the motifs themselves have very little similarity. While the 
FxxF motif and the PM motif share no obvious sequence homology, sequence alignment of 
the region containing the FxxF motif in securin orthologs alongside the ABBA motif-
containing regions of cyclin A1, cyclin A2 and BubR1 revealed multiple common features. 
For the purpose of exploring the similarity between the motifs, investigation was focused on 
cyclin A2, as this is the primary A-type cyclin expressed in the female germline (Touati et al. 
2012). 
Both the FxxF motif in securin and the ABBA motif in cyclin A2 typically center around two 
aromatic residues, either phenylalanine, tyrosine or histidine, in positions 1 and 4, with an 
upstream proline rich region and a downstream acidic region (Fig. 6.1A). Furthermore, both 
the FxxF motif of securin and the ABBA motif of cyclin A2 are found in unstructured regions 
~50 amino acids downstream of the D-box, while the PM motif of cyclin B1 is located within 
the N-terminal Helix and is ~120 amino acids downstream of the D-box (Fig. 6.1B).  
Due to these common features it became a primary interest to explore how cyclin A2 was 
regulated in meiosis and if in fact the FxxF motif in securin was working to directly liberate 
Cdc20 from MCC sequestration via a similar mechanism to the ABBA motif of cyclin A2 in 
mitosis (Di Fiore et al. 2015).  
 
6.2.2 Cyclin A2 degradation in mouse oocytes begins in early prometaphase I 
and relies on the Cdk-binding cyclin box/folds. 
To investigate the regulation of cyclin A2 in meiosis, initially two constructs were tested, a 
full-length cyclin A2 (cyclin A2 FL) and a truncated version of cyclin A2 containing only the 
first N-terminal 165 residues (cyclin A2 N165, Fig. 6.2A). Both constructs contain the D-box 
and ABBA motif, however cyclin A2 N165 critically lacks the cyclin box/folds essential for 
Cdk binding (Di Fiore & Pines 2010). Cyclin A2 FL was consistently targeted from early  
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Figure 6.1. The FxxF motif in securin resembles an ABBA motif in both positioning and 
sequence. (A) Alignment of FxxF motif-containing region in securin orthologs alongside ABBA 
motif-containing regions from human cyclin A1, cyclin A2 and BubR1. (B) Schematic representa-
tion showing relative positioning of APC/C degrons within securin, cyclin A2 and cyclin B1. 
Major structural features are represented by a thick black line, unstructured regions by a thin black 
line and known degrons highlighted in red. A potential PM motif in cyclin A2 is highlighted in 
yellow and will be discussed later. All features are to scale.
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D.
Figure 6.2. The D-box and ABBA motif of cyclin A2 are not sufficient for early promet-
aphase degradation in meiosis. (A) Schematic showing VFP-tagged cyclin A2 and securin 
truncations and mutations. (B) Average cyclin A2 FL::VFP (purple, n=22) and cyclin A2 
N165::VFP (light blue, n=26) destruction profiles aligned at PB1 extrusion. (C) Average 
securin FL::VFP (orange, n=25) and cyclin A2 N165::VFP (light blue, n=26) destruction 
profiles aligned at PB1 extrusion. (D) Average cyclin A2 N165::VFP (light blue, n=26) and 
cyclin A2 N165 ABBA mutant::VFP (red, n=22) destruction profiles aligned at PB1 extru-
sion. Fine traces represent destruction profiles from individual oocytes, heavy traces repre-
sent the average destruction profile resulting from all injected oocytes of a given contsruct.
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prometaphase and had a relatively slow rate of degradation over a period of ~8 hours, 
eventually reaching a minimum in time with PB1 extrusion (Fig. 6.2B). In contrast, cyclin A2 
N165 was completely stable during early prometaphase and only began to be degraded ~2 
hours ahead of PB1 extrusion. Therefore the D-box and ABBA motif together are not 
sufficient to mediate early prometaphase I degradation of cyclin A2. Furthermore, when 
cyclin A2 N165 was injected alongside securin FL, it was observed that securin was the 
preferred substrate as N165 degradation began ~1 hour after securin FL (Fig. 6.2C). 
Interestingly, a cyclin A2 N165 construct lacking its ABBA motif (cyclin A2 N165 ABBA 
mutant) was targeted for degradation approximately an hour after N165, demonstrating that 
the ABBA motif does function at this late stage (Fig. 6.2D). 
 
6.2.3 Cks1 binding is required for early prometaphase cyclin A2 destruction in 
mouse oocytes. 
The regions containing the FxxF motif in securin and the ABBA motif in cyclin A2 show 
strong sequence homology (Fig. 6.2A) and indeed when cyclin A2 is truncated to N165, a 
construct far more similar to securin (a largely unstructured protein unable to bind Cdk1, yet 
still containing the D-box and additional degrons), it instead became a target for degradation 
only 2 hours ahead of PB1 extrusion (Fig. 6.2B). This suggests that rather than a difference in 
degrons, the dramatic timing difference between cyclin A2 and securin targeting (~5.5 hours) 
is largely due to the fact cyclin A2 can associate with a Cdk and therefore be targeted to the 
APC/C via Cks1.  
In mitotic cells, early prometaphase cyclin A2 degradation is enabled by Cks1 interaction 
through Cdk2, which targets cyclin A2 to the phosphorylated APC/C early in mitosis 
(Wolthuis et al. 2008; Di Fiore & Pines 2010). To test whether the difference in degradation 
timings between cyclin A2 and securin was in fact largely due to Cks1 targeting of cyclin A2 
to the APC/C, a number of Cks1-linked constructs were made (Fig 6.3A). Linking cyclin A2 
N165 to Cks1 with a short neutral linker (cyclin A2 N165-Cks1) brought forward destruction 
which now began as early as 7 hours ahead of PB1 extrusion. Thereby partially rescuing the 
early prometaphase degradation of cyclin A2 FL (Fig 6.3B). This early degradation was 
however more gradual than cyclin A2 FL during early prometaphase. Cyclin A2 N165-Cks1 
instead showed an increased rate of destruction in the last 4 hours before PB1 extrusion, this 
is in contrast to cyclin A2 FL where the rate of destruction is largely constant (Fig 6.3B). 
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Figure 6.3. Cks1 binding is required for early prometaphase cyclin A2 destruction in 
oocytes. (A) Schematic showing VFP-tagged cyclin A2 and securin truncations and mutations 
alongside Cks1-linked constructs. (B) Average cyclin A2 N165-Cks1::VFP (green, n=12), cyclin 
A2 FL::VFP (purple dashed, n=22) and cyclin A2 N165::VFP (light blue dashed, n=26) destruc-
tion profiles aligned at PB1 extrusion. (C) Cks1 residues 118-147 sequence detail showing the 
nomenclature of Venus-tagged Cks1 mutations. (D) Average cyclin A2 N165-Cks1::VFP (green 
dashed, n=12), cyclin A2 N165-Cks1 APC/C mutant::VFP (purple, n=15), cyclin A2 N165-Cks1 
APC/C+Skp2 mutant::VFP (red, n=9) and cyclin A2 N165::VFP (light blue dashed, n=26) 
destruction profiles aligned to PB1 extrusion. (E) Average securin FL-Cks1::VFP (dark blue, 
n=12) and securin FL::VFP (orange dashed, n=25) destruction profiles aligned at PB1 extrusion. 
(F) Average cyclin A2 N165-Cks1::VFP (green, n=12) and securin FL-Cks1::VFP (dark blue, 
n=12) destruction profiles aligned at PB1 extrusion. (G) Average securin FL-Cks1::VFP (dark 
blue dashed, n=12), securin FL-Cks1 APC/C mutant::VFP (purple, n=15), securin FL-Cks1 
APC/C+Skp2 mutant::VFP (red, n=13) and securin FL::VFP (orange dashed, n=25) destruction 
profiles aligned to PB1 extrusion. Fine traces represent destruction profiles from individual 
oocytes, heavy traces represent the average destruction profile resulting from all injected 
oocytes of a given contruct.
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To test whether linking cyclin A2 N165 to Cks1 caused early degradation by specific 
targeting to the phosphorylated APC/C during early prometaphase and not through interfering 
with protein structure for example, the anion-binding site in Cks1 was mutated (Cks1 APC/C 
binding mutant; Watson et al. 1996; Fig.6.3C). Cyclin A2 N165-Cks1 APC/C mutant was 
targeted for degradation at a slower rate than cyclin A2 N165-Cks1, yet some degradation still 
took place from early prometaphase (Fig. 6.3D). I hypothesised that this persisting 
degradation could be due to the previously reported Cks1 association with Skp2, the F-box 
protein component of the SCF E3 ubiquitin ligase (Sitry et al. 2002). Indeed, when both the 
anion-binding site and two residues highlighted to be important in Skp2-binding (Sitry et al. 
2002) were mutated together (A2 N165-Cks1 APC/C+Skp2 mutant; Fig. 6.3C), destruction 
was observed in time with cyclin A2 N165 (Fig. 6.3D). 
I reasoned that if Cks1 was able to permit ABBA-mediated cyclin A2 destruction from early 
prometaphase even without Cdk interaction, then fusing Cks1 to securin may also allow for 
early prometaphase degradation. Indeed, securin FL-Cks1 degradation consistently began 
from GV stage and continued at a similar rate until ~4 hours ahead of PB1 extrusion when the 
rate increased, reaching a minimum in time with polar body extrusion (Fig. 6. 3E). While 
securin FL-Cks1 was targeted from GV stage, ahead of cyclin A2 N165-Cks1, from mid to 
late prometaphase the two constructs show similar destruction profiles (Fig. 6.3F). 
Surprisingly however, when securin FL-Cks1 was mutated at the Cks1 anion-binding site 
(securin FL-Cks1 APC/C mutant), rather than simply a reduced early degradation (as in the 
case of cyclin A2 N165-Cks1 APC/C mutant) the construct was instead rapidly degraded to 
50% by 5 hours ahead of PB1 extrusion (Fig. 6.3G). How inhibiting the APC/C interaction 
could actually make this protein a better substrate is very interesting. I hypothesised that again 
this may be due to Cks1 interaction with Skp2 and subsequent SCF-mediated degradation. 
Perhaps by removing the capacity for Cks1 interaction with the APC/C, this increases the 
portion of the construct targeted to Skp2. Increased initial degradation may be due to the 
presence of a previously identified SCF recognition motif (DDAYPE) within the C-terminus 
of securin (Limón-Mortés et al. 2008), not present in cyclin A2, hence why we did not see the 
effect with cyclin A2 N165-Cks1 APC/C mutant. 
However, mutation of both the anion-binding site and the two Skp2-interacting residues does 
not fully stabilise prometaphase destruction (Fig. 6.3G). Note that while securin FL-Cks1 
degradation rate accelerates ~3 hours ahead of PB1 extrusion, APC/C+Skp2 mutant 
degradation only increases in the last 2 hours before PB1 extrusion. 
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 6.2.4 The ABBA motif is essential for early cyclin A2 degradation in mouse 
oocytes. 
In nocodazole-treated mitotic cells, when the ABBA motif in cyclin A2 is mutated, though the 
rate of degradation decreases, the mutant is still fully degraded (Di Fiore et al. 2015). This is 
in contrast to the equivalent securin FxxF-A mutant which is largely stabilised in nocodazole-
arrested oocytes (Chapter 5). This prompted the question of whether cyclin A2 contained yet 
further regions promoting degradation during an active checkpoint. Indeed after sequence 
alignment and conservation analysis, it was found that the PM motif responsible for late 
prometaphase I destruction of cyclin B1 is present in all A- and B-type cyclins in humans, yet 
lost in D- and E-type cyclins (Fig 6.4A). Indeed the motif is highly conserved in cyclins B1 
and A2 through Metazoa (Fig. 6.4B-C) and is present in various cyclins of both budding and 
fission yeast, where the ABBA motif is either divergent or lost completely (Fig. 6.4D-E). 
To assess the functionality of this conserved PM motif within cyclin A2, two full-length 
mutant cyclin A2 constructs were tested, one with the ABBA motif mutated (cyclin A2 FL 
ABBA mutant) and one with the PM motif mutated (cyclin A2 FL PM mutant) alongside 
cyclin A2 FL, containing both motifs, and cyclin A2 N165 ABBA containing neither (Fig. 
6.5A). It is important to note that all constructs contain a D-box. Though cyclin A2 FL PM 
mutant was consistently targeted for degradation from early prometaphase, the rate of 
destruction was slow over the first 6 hours compared to cyclin A2 FL. This was followed by a 
sharp increase in degradation in the last hour before PB1 extrusion, reminiscent of the cyclin 
B1 PM mutant as seen in chapter 3 (Fig 6.5B). However, at present we do not have a tested 
cyclin A2 mutant where Cdk interaction is inhibited (a cyclin B1 Y170A equivalent; see 
chapter 3). Without a control mutation in both WT and PM mutant constructs, any changes in 
degradation profile could simply be due to an altered affinity of Cdk and in turn Cks1 
binding. As such, while the features of this curve make it tempting to speculate, it is currently 
not possible to draw any conclusions regarding the function of a cyclin A2 PM motif without 
such a control.  
Cyclin A2 FL ABBA mutant is only a destruction target in the last ~2 hours before PB1 
extrusion, however here destruction is rapid (Fig. 6.5C). This is in contrast to mitosis where 
the reverse is true, mutating the ABBA motif reduces the rate of degradation but does not 
affect the timing (Di Fiore et al. 2015). Note the particularly late targeting of the cyclin A2 
N165 ABBA mutant. This construct contains only a D-box and was expected to be destroyed 
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in time with the cyclin B1 PM mutant. Instead it appears that the D-box of cyclin B1 is 
preferred to the D-box of cyclin A2 at this late time point (Fig. 6.5D). 
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 Figure 6.4. The PM motif is conserved in A- and B-type cyclins through Metazoa and 
various cyclins in both budding and fission yeast. (A) Alignment of PM motif-containing 
region in human cyclins, showing conservation in A- and B-type cyclins but loss in D- and 
E-type cyclins. (B) Alignment of PM motif-containing region in cyclin B1 orthologs. (C) 
Alignment of PM motif-containing region in cyclin A2 orthologs. (D) Alignment of PM 
motif-containing region in budding yeast cyclins. (E) Alignment of PM motif-containing 
region in fission yeast cyclins. The MRAIL motif, important in Cdk binding, is highlighted as 
a common feature of most cyclins. Note the conservation of the relative positioning of the PM 
motif ~18-22 residues upstream of the MRAIL motif. 
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Figure 6.5. The ABBA motif in cyclin A2 is essential for early prometaphase degradation 
in mouse oocytes. (A) Schematic showing VFP-tagged cyclin A2 and cyclin B1 truncations and 
mutations. (B) Average cyclin A2 FL::VFP (purple, n=22), cyclin A2 FL PM mutant::VFP 
(orange, n=14) and cyclin A2 N165 ABBA mutant::VFP (dark blue dashed, n=22) destruction 
profiles aligned at PB1 extrusion. (C) Average cyclin A2 FL::VFP (purple dashed, n=22) and 
cyclin A2 FL ABBA mutant::VFP (red, n=14) destruction profiles aligned at PB1 extrusion. (D) 
Average cyclin A2 N165 ABBA mutant::VFP (blue, n=22), cyclin B1 Y170A::VFP (red dashed, 
n=32) and cyclin B1 PM mutant::VFP (blue dashed, n=28) destruction profiles aligned at PB1 
extrusion. Fine traces represent destruction profiles from individual oocytes, heavy traces 
represent the average destruction profile resulting from all injected oocytes of a given construct.
Cyclin B1 Y170A 
Cyclin A2 N165 ABBA mutant 
Cyclin B1 PM mutant
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6.3 Discussion 
In chapters 3 and 4, two novel motifs were identified, the PM motif in cyclin B1 and the FxxF 
motif in securin that function to permit destruction in late prometaphase I during an active 
checkpoint. Whilst the degradation timings of cyclin B1 and securin are seemingly identical 
in both wild-type constructs and in PM/FxxF mutant constructs, the motifs share no 
discernable similarity either in sequence or position relative to key domains. While the PM 
motif forms part of the N-terminal helix of cyclin B1, the FxxF motif is found within an 
unstructured region of securin (Fig. 6.1B). It therefore seems likely that these degrons act to 
bypass the checkpoint via distinct mechanisms.  
Sequence alignment and conservation analysis of other known APC/C degrons revealed that 
the FxxF motif in securin shares a number of common features with the ABBA motif recently 
identified in cyclin A1, cyclin A2, Bub1 and BubR1 (Di Fiore et al. 2015). Both motifs 
typically center around two aromatic residues, either phenylalanine, tyrosine or histidine, in 
positions 1 and 4, with an upstream proline rich region and a downstream acidic region (Fig. 
6.1A). Whilst the FxxF motif does not exactly fit the consensus ABBA motif sequence 
(Fx[ILV][FHY]x[DE]), it is important to note that the ABBA motif is the most recently 
characterised APC/C degron and has only been identified a handful of proteins and is 
therefore likely to evolve as more cases are identified. Also important to note is that ABBA 
motif in cyclin A was identified using a computational motif search (SLiMSearch; Davey et 
al. 2011) rather than from experimental data. While the minimal consensus D-box motif is 
RxxL, there are a number of experimentally identified D-box degrons that do not fit this such 
as cyclin B3 which has a phenylalanine rather than a leucine in position 4 (Nguyen et al. 
2002). Such studies highlight a level of flexibility even in an APC/C degron as well defined 
as the D-box. 
Our data shows that cyclin A2 degradation from early prometaphase I is mediated by Cks1 
targeting to the phosphorylated APC/C.  A cyclin A2 N165 truncation which includes both 
the D-box and the ABBA motif, yet lacks Cdk-binding modules is not able to form a complex 
with Cks1 and only becomes an APC/C target in late prometaphase (Fig. 6.2B). This suggests 
that while the ABBA motif is essential for a wild-type degradation, the difference between 
early and late prometaphase APC/C targeting was largely a result of a presence or absence of 
Cks1. The ABBA motif may offer a higher affinity for the APC/C, but this interaction is only 
possible when coupled to Cks1-directed recruitment. Indeed, cyclin A2 N165 was targeted an 
hour after securin FL in late prometaphase suggesting that at this earlier time point the D-box 
87
and FxxF motif of securin have the higher combined binding affinity than the D-box and 
ABBA motif of cyclin A2 in the absence of Cks1 binding (Fig. 6.2C-D).  
Early prometaphase degradation was rescued by linking cyclin A2 N165 to Cks1 (Fig. 6.3B), 
thus confirming that without Cks1, the D-box and ABBA motif together are insufficient to 
mediate destruction in early prometaphase. Furthermore, when the linked Cks1 protein 
contained mutations removing both APC/C and Skp2 interactions, this rescue was abolished 
(Fig. 6.3F). Interestingly, the APC/C binding mutation alone did not completely abolish the 
rescue, suggesting that some level of degradation can be mediated via the SCF through direct 
interaction of Cks1 and the F-box protein Skp2. This finding is supported by a previous study 
reporting an interaction between cyclin A2-Cdk2 and Skp2 (Yam et al. 1999). 
It seemed plausible that the dramatic difference in degradation timing between cyclin A2 and 
securin may be largely due to Cks1 targeting and that in fact the motifs may function in the 
same way if similarly localised. To test this, securin was linked to Cks1. Indeed the linked 
construct was targeted for degradation from early prometaphase. However somewhat 
unexpectedly, wild-type degradation in late prometaphase was not recovered when both 
APC/C and Skp2 interacting residues were mutated in Cks1. Whether the FxxF motif can act 
as an ABBA motif in early prometaphase remains under investigation. Ongoing 
immunoprecipitation experiments to assess whether the FxxF motif can directly bind to 
Cdc20’s ABBA interacting region will further address this.  
In chapter 5, it was demonstrated that late prometaphase degradation of securin is a regulated 
mechanism, mediated by discrete motifs which permit securin to bypass the spindle 
checkpoint. An FxxF-A mutant securin was stabilised in nocodazole-treated oocytes. This is 
in contrast to the ABBA motif in mitotic cyclin A2 destruction, where a cyclin A2 ABBA 
mutant was still fully degraded in nocodazole-arrested cells, albeit at a reduced rate (Di Fiore 
et al. 2015). This prompted the question whether cyclin A2 contained additional regions able 
to mediate degradation during an active checkpoint. Sequence alignment and conservation 
analysis revealed a conserved PM motif within the N-terminal helix of cyclin A2 (showing 
high sequence homology to the motif identified in cyclin B1, Fig. 6.4B-C). This conservation 
carried through to budding and fission yeast cyclins, both of which hold PM motifs 
consistently ~20 residues upstream of the MRAIL motif critical for Cdk binding (Fig. 6.4D-E; 
Schulman et al 1998), suggesting this may have important evolutionary significance. 
Interestingly, while a functional ABBA motif does exist in budding yeast Clb5 (Lu et al. 
2014), it bears little resemblance to the mammalian ABBA motif and is completely absent in 
fission yeast cyclins. It could be argued that the PM motif is so well conserved simply 
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because it has a role to play in Cdk binding, however human D- and E- type cyclins also have 
Cdk partners and a well conserved MRAIL motif, yet no PM motif. 
We suggest that cyclin A2 contains 3 APC/C degrons; a D-box, an ABBA motif with high 
sequence homology to the FxxF motif in securin and a PM motif with high sequence 
homology to that of cyclin B1. To test the functionality of the PM motif would require a non 
Cdk-binding cyclin A2 with and without a PM motif mutation. An example of this could be a 
cyclin A2 truncation after the N-terminal helix at around residue 230.  
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Chapter 7: Conclusion and final remarks. 
 
Accurate cell division is a strictly ordered, highly regulated event that requires complex 
regulation in order to avoid chromosomal segregation errors during the metaphase to 
anaphase transition. Errors during segregation often lead to generation of aneuploid daughter 
cells; cells containing an incorrect number of inherited chromosomes. In mitosis, a robust 
spindle checkpoint ensures that chromosome division errors occur at a relatively low 
frequency, by maintaining high levels of cyclin B1 and securin until chromosomes are 
accurately aligned on the metaphase plate. In contrast, human oocyte meiosis is extremely 
error prone, with chromosomal abnormalities estimated to be present in as many as 30% of 
fertilised eggs in younger women, possibly exceeding 50% in those who conceive later in 
their reproductive lifespan (Hassold & Hunt 2001). This meiotic aneuploidy is the primary 
genetic cause of miscarriage, congenital disability and mental retardation in foetuses that 
survive to term (Hassold & Hunt 2001).  
It is well observed that in meiosis I mouse oocytes, cyclin B1 and securin degradation initiate 
in late prometaphase (Homer et al. 2005; Lane et al. 2012) at a time when the spindle is yet to 
fully migrate to the cortex (Verlhac et al. 2000; Kitajima et al. 2011) and checkpoint proteins 
are still detected at kinetochores (Lane et al. 2012). This has often been viewed as precocious 
degradation, missed by a checkpoint that has become insufficient over the large volume of an 
oocyte. Indeed, the spindle checkpoint does appear to be less robust in oocytes as MPS1 
localisation to kinetochores and subsequent kinetochore-dependent MCC assembly is 
essential for correct prometaphase timing (Hached et al. 2011). In contrast, in mitotic cells 
MCC complex formation within the cytoplasm is sufficient for correct cell cycle progression 
(Maciejowski et al. 2010). Thus a diffusible checkpoint able to block premature progression 
in mitotic cells is not sufficient in oocytes. While a diluted checkpoint may seem like an 
attractive explanation for the high rates of aneuploidy observed in human oocytes, mouse 
oocytes are comparable in size and chromosome number but are far less error prone with an 
estimated 1-2% of fertilised eggs being aneuploid (Bond & Chandley 1983), compared to 25-
30% in human eggs (Hassold & Hunt 2001). This implies that cyclin B1 and securin 
destruction in late prometaphase I is not responsible for segregation errors and consequently 
seemed worthy of further investigation. 
We show that degradation of cyclin B1 and securin in late prometaphase I is not simply due to 
an insufficient checkpoint but in fact due to controlled novel mechanisms of destruction 
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within the oocyte. Meiotic destruction of cyclin B1 and securin can be split into two distinct 
periods; a later period of destruction that resembles mitotic destruction where the D-box is 
sufficient for APC/C targeting, and a much earlier period of destruction requiring additional 
previously unidentified motifs able to bypass the spindle checkpoint. The PM motif in cyclin 
B1 and the FxxF motif in securin constitute novel regions that work alongside a D-box to 
mediate degradation during an active checkpoint.  
Due to the location of these motifs within the proteins, they are likely to be masked when 
bound to their respective partner proteins; cyclin B1 to Cdk1 and securin to separase. This is 
supported by the crystal structures of both complexes (Brown et al. 2015; Luo & Tong 2017). 
We therefore propose a mechanism by which free pools of cyclin B1 and securin are targeted 
preferentially ahead of bound pools in which the PM motif and FxxF motif respectively 
would be obscured. This preferential targeting of unbound pools would protect Cdk1 activity 
and separase inhibition when the spindle checkpoint may become insufficient over the 
extended prometaphase period in the huge cell volume of an oocyte.  
Key experiments to prove this model will involve determination of securin:separase ratio in 
oocytes, followed by knock down of securin protein level to mimic a mitotic ratio and 
subsequent measurement of separase activity in a securin knock down background. These 
would mimic cyclin B1 knock down experiments from our lab in which oocytes are unable to 
maintain Cdk1 activity and extrude abnormal polar bodies when cyclin B1 protein levels are 
knocked down such that oocytes contain ~2-fold rather than the usual ~6-fold excess at 5.5 
hours post GVBD (Levasseur et al. 2017 unpublished). 
It has been suggested that each APC/C substrate is governed in a unique way, ensuring 
delivery to the proteasome at a particular time and in a specific order (Lu et al. 2014). In the 
case of cyclin B1 and securin, we expand upon this and suggest processing in a way that is 
unique to binding state. Our research provides a new insight into fundamental aspects of cell 
cycle control in meiosis I mouse oocytes, relevant to our understanding of the high rates of 
aneuploidy in human eggs. We provide substantial evidence for oocyte-specific mechanisms 
which protect the oocyte from an increased incidence of division error. Destruction 
mechanisms utilising degrons that would otherwise be masked in complex may be a common 
principle of proteostasis, this has been suggested (Ravid & Hochstrasser 2008; Harper & 
Bennett 2016; Davey & Morgan 2016). The position of such degrons allows control over the 
balance of individual subunits of complexes where their balance becomes misregulated. We 
would suggest that the oocyte may be exploiting such mechanisms to control the activity of 
key cell cycle regulators.  
92
We have revised our understanding of both the timing of the oocyte cell cycle and the 
regulation of cyclin B1, cyclin A2 and securin. Our findings will aid the search for the origins 
of aneuploidy in oocytes and the design of treatment strategies for women who suffer 
repetitive miscarriages, a substantial contributor to human infertility. In certain cases, 
recurrent miscarriage may be due to an imbalance in the ratio of cyclin B1:Cdk1 or 
securin:separase. Furthermore, given the general conservation of molecular mechanisms in 
the control of both mitotic and meiotic cell cycles, it is possible that the PM motif and FxxF 
motif have additional mitotic functions in the ‘housekeeping’ of cyclin B1 and securin protein 
levels, or the slippage of cells out of drug-induced mitotic arrest. Beyond cell division, it 
seems plausible that the masking and unveiling of degrons has a key role to play in 
proteostasis.  
While an error-prone spindle assembly and large cell volume clearly contribute to the high 
levels of aneuploidy observed in human oocytes, it is also of critical interest whether the 
protective mechanisms we have identified in mouse oocytes are conserved in humans. Spindle 
assembly in human oocytes lasts up to 16 hours compared to 3-5 hours in mice (Holubcova et 
al. 2015). A human oocyte would therefore need much larger excesses of cyclin B1 and 
securin in order to protect Cdk1 activity and separase inhibition over such an extended time 
period. The situation in aged oocytes is also very interesting. While all of our studies have 
been conducted in young mice, we can speculate that the balance of cyclin B1:Cdk1 and 
securin:separase could be perturbed with age, contributing to the age-dependent exponential 
increase in error alongside other known problems associated with aged oocytes. 
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Appendix I: Abbreviations 
 
APC/C Anaphase promoting complex or cyclosome 
CHX Cycloheximide 
CPC Chromosome passenger complex 
FL Full-length 
FRET Förster resonance energy transfer 
GFP Green fluorescent protein 
GV Germinal vesicle 
GVBD Germinal vesicle breakdown 
I2PP2A PP2A inhibitor 2 
IBMX 3-isobutyl-1-methyl xanthine  
LH Luteinising hormone 
MI First meiotic division 
MII Second meiotic division 
MCC Mitotic checkpoint complex 
MEFs Mouse embryonic fibroblasts 
MO Morpholino oligomer 
MTOC Microtubule organising centre 
NEBD Nuclear envelope breakdown 
NTH N-terminal helix 
PB1 First polar body extrusion 
PP2A Protein phosphatase 2A 
RT Room temperature 
SCF Skp1-Cullin-F-box complex 
Sgo Shugoshin 
SLIC Sequence- and ligation-independent cloning 
VFP Venus fluorescent protein 
WT Wild-type 
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